A rare cause of stroke at a young age: ischemic stroke by the mechanism of paradoxical embolism in a patient with hereditary hemorrhagic telangiectasia ; Редкая причина инсульта в молодом возрасте: ишемический инсульт по механизму парадоксальной эмболии у пациента с наследственной геморрагической телеангиэктазией

Συγγραφείς: A. V. Belopasova, P. S. Shlapakova, L. A. Dobrynina, A. S. Kadykov, А. В. Белопасова, П. С. Шлапакова, Л. А. Добрынина, А. С. Кадыков

Συνεισφορές: The investigation has not been sponsored, Исследование не имело спонсорской поддержки

Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 15, No 6 (2023); 78-84 ; Неврология, нейропсихиатрия, психосоматика; Vol 15, No 6 (2023); 78-84 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2023-6

Θεματικοί όροι: инсульт в молодом возрасте, hereditary hemorrhagic telangiectasia, Rendu–Osler–Weber disease, pulmonary arteriovenous malformation, paradoxical embolism, stroke at a young age, наследственная геморрагическая телеангиэктазия, болезнь Рандю–Ослера–Вебера, легочная артериовенозная мальформация, парадоксальная эмболия

Περιγραφή αρχείου: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/2142/1609; Добрынина ЛА, Калашникова ЛА, Павлова ЛН. Ишемический инсульт в молодом возрасте. Журнал неврологии и психиатрии им. С.С. Корсакова. 2011;111(3):4-8.; Schöberl F, Ringleb PA, Wakili R, et al. Juvenile Stroke. Dtsch Arztebl Int. 2017 Aug 7;114(31-32):527-34. doi:10.3238/arztebl.2017.0527; Hart RG, Catanese L, Perera KS, et al. Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update. Stroke. 2017 Apr;48(4):867-72. doi:10.1161/STROKEAHA.116.016414. Epub 2017 Mar 6.; Кулеш АА, Демин ДА, Виноградов ОИ. Криптогенный инсульт. Часть 1: аорто-артериальная эмболия. Медицинский совет. 2021;(4):78-87. doi:10.21518/2079-701X-2021-4-78-87; Li L, Yiin GS, Geraghty OC, et al; Oxford Vascular Study. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol. 2015 Sep;14(9):903-13. doi:10.1016/S14744422(15)00132-5. Epub 2015 Jul 27.; Putaala J, Nieminen T, Haapaniemi E, et al. Undetermined stroke with an embolic pattern – a common phenotype with high early recurrence risk. Ann Med. 2015;47(5):406-13. doi:10.3109/07853890.2015.1057612. Epub 2015 Aug 4.; Faughnan ME, Mager JJ, Hetts SW, et al. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Ann Intern Med. 2020 Dec 15;173(12):989-1001. doi:10.7326/M20-1443. Epub 2020 Sep 8.; Rendu M. Epistaxis repetes chez unsujet porteur de petits angiomies cutaneset muqueux. Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris. 1886;13:731-3 (In French).; Osler W. On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Johns Hopkins Med J. 1901;12:333.; Weber FP. Multiple hereditary developmental angiomata (telangiectases) of the skin and mucous membranes associated with recurring haemorrhages. Lancet. 1907;170:160-2.; Hanes FM. Multiple hereditary telangiectases causing hemorrhages. Bull John Hopkins Hospital. 1909;20:63-73.; Macri A, Wilson AM, Shafaat O, Sharma S. Osler-Weber-Rendu disease (hereditary hemorrhagic telangiectasia, HHT). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing LLC. 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482361/; Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-OslerWeber syndrome). Am J Med Genet. 2000 Mar 6;91(1):66-7. doi:10.1002/(sici)10968628(20000306)91:13.0.co;2-p; Faughnan ME, Palda VA, Garcia-Tsao G, et al; HHT Foundation International – Guidelines Working Group. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011 Feb;48(2):73-87. doi:10.1136/jmg.2009.069013. Epub 2009 Jun 23.; Pahl KS, Choudhury A, Wusik K, et al. Applicability of the CuraНao Criteria for the Diagnosis of Hereditary Hemorrhagic Telangiectasia in the Pediatric Population. J Pediatr. 2018 Jun;197:207-13. doi:10.1016/j.jpeds.2018.01.079. Epub 2018 Apr 11.; Morgan T, McDonald J, Anderson C, et al. Intracranial hemorrhage in infants and children with hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu syndrome). Pediatrics. 2002 Jan;109(1):E12. doi:10.1542/peds.109.1.e12; Schoonderwoerd MJA, Goumans MTH, Hawinkels LJAC. Endoglin: Beyond the Endothelium. Biomolecules. 2020 Feb 12;10(2):289. doi:10.3390/biom10020289; Berg J, Porteous M, Reinhardt D, et al. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet. 2003 Aug;40(8):585-90. doi:10.1136/jmg.40.8.585; Bayrak-Toydemir P, McDonald J, Markewitz B, et al. Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet A. 2006 Mar 1;140(5):463-70. doi:10.1002/ajmg.a.31101; McDonald J, Wooderchak-Donahue W, VanSant Webb C, et al. Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet. 2015 Jan 26;6:1. doi:10.3389/fgene.2015.00001; Halpern M, Turner AF, Citron BP. Hereditary hemorrhagic telangiectasia. An angiographic study of abdominal visceral angiodysplasias associated with gastrointestinal hemorrhage. Radiology. 1968 Jun;90(6):1143-9. doi:10.1148/90.6.1143; Dupuis-Girod S, Cottin V, Shovlin CL. The Lung in Hereditary Hemorrhagic Telangiectasia. Respiration. 2017;94(4):315-30. doi:10.1159/000479632. Epub 2017 Aug 30.; White RI Jr, Lynch-Nyhan A, Terry P, et al. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology. 1988 Dec;169(3):663-9. doi:10.1148/radiology.169.3.3186989; Белопасова АВ, Добрынина ЛА, Калашникова ЛА и др. Легочный артериовенозный шунт – редкая причина рецидивирующих нарушений мозгового кровообращения по механизму парадоксальной эмболии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(9):107-13. doi:10.17116/jnevro2020120091107; Байдарова МД, Тупикин КА, Андрейцева ОИ. Наследственная геморагическая телеангиэктазия: современные проблемы диагностики и тактики хирургического лечения. Доказательная гастроэнтерология. 2016;(4):36-43. doi:10.17116/dokgastro20165436-43; Кулеш АА, Демин ДА, Белопасова АВ и др. Криптогенный инсульт. Часть 2: парадоксальная эмболия. Медицинский совет. 2021;(19):16-33. doi:10.21518/2079701X-2021-19-16-33; Shovlin CL, Jackson JE, Bamford KB, et al. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax. 2008 Mar;63(3):259-66. doi:10.1136/thx.2007.087452. Epub 2007 Nov 2.; Jauss M, Zanette E. Detection of right-toleft shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis. 2000 Nov-Dec;10(6):490-6. doi:10.1159/000016119; Silvestry FE, Cohen MS, Armsby LB, et al; American Society of Echocardiography; Society for Cardiac Angiography and Interventions. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr. 2015 Aug;28(8):910-58. doi:10.1016/j.echo.2015.05.015; Чечеткин АО, Каршиева АР, Кравченко МА и др. Легочный артерио-венозный шунт как причина парадоксальной церебральной эмболии: возможности ультразвуковой диагностики. Известия Российской Военно-медицинской академии. 2019;38(3):162-4. doi:10.17816/rmmar26170

Διαθεσιμότητα: https://nnp.ima-press.net/nnp/article/view/2142
https://doi.org/10.14412/2074-2711-2023-6-78-84

Paradoxial embolism as a cause of ischemic stroke in patient with sinus venosus atrial septal defect ; Ишемический инсульт по механизму парадоксальной эмболии на фоне дефекта межпредсердной перегородки типа sinus venosus

Συγγραφείς: A. A. Kulesh, S. A. Mekhryakov, L. I. Syromyatnikova, N. H. Gorst, S. O. Drobakha, E. V. Nikolaeva, А. А. Кулеш, С. А. Мехряков, Л. И. Сыромятникова, Н. Х. Горст, С. О. Дробаха, Е. В. Николаева

Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 13, No 5 (2021); 123-129 ; Неврология, нейропсихиатрия, психосоматика; Vol 13, No 5 (2021); 123-129 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2021-5

Θεματικοί όροι: парадоксальная эмболия, atrial septal defect, sinus venosus, paradoxial embolism, дефект межпредсердной перегородки

Περιγραφή αρχείου: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/1676/1321; https://nnp.ima-press.net/nnp/article/view/1676/1329; Ekker MS, Boot EM, Singhal AB, et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol. 2018 Sep;17(9):790-801. doi:10.1016/S1474-4422(18)30233-3; Renna R, Pilato F, Profice P, et al. Risk factor and etiology analysis of ischemic stroke in young adult patients. J Stroke Cerebrovasc Dis. 2014 Mar;23(3):e221-7. doi:10.1016/j.jstrokecerebrovasdis.2013.10.008. Epub 2014 Jan 11.; Калашникова ЛА, Добрынина ЛА. Ишемический инсульт в молодом возрасте. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2017;117(8):3-12. doi:10.17116/jnevro2017117823-12; Кулеш АА, Нуриева ЮА, Сыромятникова ЛИ. Причины ишемического инсульта у пациентов моложе 45 лет: анализ данных регионального сосудистого центра. Неврология, нейропсихиатрия, психосоматика. 2021;13(1):24-30. doi:10.14412/2074-2711-2021-1-24-30; Кулеш АА, Огнерубов ДВ, Мехряков СА и др. Инсульт, ассоциированный с открытым овальным окном: подходы к диагностике и возможности эндоваскулярной профилактики (клинические наблюдения и обзор литературы). Неврология, нейропсихиатрия, психосоматика. 2020;12(2):72-78. doi:10.14412/2074-2711-2020-2-72-78; Кулеш АА, Шестаков ВВ. Открытое овальное окно и эмболический криптогенный инсульт. Неврология, нейропсихиатрия, психосоматика. 2019;11(2):4-11. doi:10.14412/2074-2711-2019-2-4-11; Leppert M, Poisson SN, Carroll JD. Atrial Septal Defects and Cardioembolic Strokes. Cardiol Clin. 2016 May;34(2):225-30. doi:10.1016/j.ccl.2015.12.004. Epub 2016 Mar 9.; Bradley EA, Zaidi AN. Atrial Septal Defect. Cardiol Clin. 2020 Aug;38(3):317-24. doi:10.1016/j.ccl.2020.04.001. Epub 20020 Jun 6.; Geva T, Martins JD, Wald RM. Atrial septal defects. Lancet. 2014 May 31;383(9932):1921-32. doi:10.1016/S0140-6736(13)62145-5. Epub 2014 Apr 8.; Bannan A, Shen R, Silvestry FE, Herrmann HC. Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism. Catheter Cardiovasc Interv. 2009 Dec 1;74(7):1066-9. doi:10.1002/ccd.22170; Broy C, Bennett S. Partial anomalous pulmonary venous return. Mil Med. 2008 Jun;173(6):523-4. doi:10.7205/milmed.173.6.523; Kivistö S, Hänninen H, Holmström M. Partial anomalous pulmonary venous return and atrial septal defect in adult patients detected with 128-slice multidetector computed tomography. J Cardiothorac Surg. 2011 Sep 30;6:126. doi:10.1186/1749-8090-6-126; Blake GE, Lakkireddy D. Atrial Septal Defect and Atrial Fibrillation: The Known and Unknown. J Atr Fibrillation. 2008 Sep 16;1(3):45. doi:10.4022/jafib.45. eCollection Sep-Nov 2008.; Nyboe C, Olsen MS, Nielsen-Kudsk JE, Hjortdal VE. Atrial fibrillation and stroke in adult patients with atrial septal defect and the long-term effect of closure. Heart. 2015 May;101(9):706-11. doi:10.1136/heartjnl-2014-306552. Epub 2015 Feb 17.; Berger F, Vogel M, Kramer A, et al. Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg. 1999 Jul;68(1):75-8. doi:10.1016/s0003-4975(99)00478-6; Attenhofer Jost CH, Connolly HM, Danielson GK, et al. Sinus venosus atrial septal defect: long-term postoperative outcome for 115 patients. Circulation. 2005 Sep 27;112(13):1953-8. doi:10.1161/CIRCULATIONAHA.104.493775. Epub 2005 Sep 19.; Karunanithi Z, Nyboe C, Hjortdal VE. Long-Term Risk of Atrial Fibrillation and Stroke in Patients with Atrial Septal Defect Diagnosed in Childhood. Am J Cardiol. 2017 Feb 1;119(3):461-5. doi:10.1016/j.amjcard.2016.10.015. Epub 2016 Nov 1.; Windecker S, Stortecky S, Meier B. Paradoxical embolism. J Am Coll Cardiol. 2014 Jul 29;64(4):403-15. doi:10.1016/j.jacc.2014.04.063; Cakmak S, Goldman C, Bozio A, et al. Sinus venosus-type atrial septal defect: a rare curable cause of recurrent transient neurological deficits. Stroke. 2006 Sep;37(9):2385-6. doi:10.1161/01.STR.0000236635.44539.d4. Epub 2006 Aug 10.; O'Sullivan CJ, Magarzo JG, Bernheim AM, Eberli F. Paradoxical embolism via a sinus venosus atrial septal defect causing an inferior ST-segment elevation myocardial infarction in a 23-year-old woman. BMJ Case Rep. 2016 Apr 29;2016:bcr2016215184. doi:10.1136/bcr-2016-215184; Amarenco P. Patent foramen ovale and the risk of stroke: smoking gun guilty by association? Heart. 2005 Apr;91(4):441-3. doi:10.1136/hrt.2004.052241; Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol. 2004 Jan 21;43(2):302-9. doi:10.1016/j.jacc.2003.10.030; Pascoe RD, Oh JK, Warnes CA, et al. Diagnosis of sinus venosus atrial septal defect with transesophageal echocardiography. Circulation. 1996 Sep 1;94(5):1049-55. doi:10.1161/01.cir.94.5.1049; Gaibazzi N, Montresor G, Poeta ML. Anatomy of a wrong diagnosis: false sinus venosus atrial septal defect. Cardiovasc Ultrasound. 2003 Nov 7;1:15. doi:10.1186/1476-7120-1-15; Sharma AK, Nath RK, Pandit N. A case of sinus venosus atrial septal defect misdiagnosed as primary pulmonary hypertension. Hellenic J Cardiol. 2016 MarApr;57(2):124-8. doi:10.1016/j.hjc.2016.03.005; Vodusek Z, Khaliqdina S, Borz-Baba C, Scandrett R. Sinus Venosus Atrial Septal Defect: A Challenging Diagnosis. Cureus. 2019 Oct 17;11(10):e5936. doi:10.7759/cureus.5936; Puchalski MD, Lui GK, Miller-Hance WC, et al. Guidelines for Performing a Comprehensive Transesophageal Echocardiographic: Examination in Children and All Patients with Congenital Heart Disease: Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2019 Feb;32(2):173-215. doi:10.1016/j.echo.2018.08.016

Διαθεσιμότητα: https://nnp.ima-press.net/nnp/article/view/1676
https://doi.org/10.14412/2074-2711-2021-5-123-129

Cryptogenic stroke. Part 2: paradoxical embolism ; Криптогенный инсульт. Часть 2: парадоксальная эмболия

Συγγραφείς: A. A. Kulesh, D. A. Demin, A. V. Belopasova, S. A. Mekhryakov, O. I. Vinogradov, L. I. Syromyatnikova, A. A. Ziankou, А. А. Кулеш, Д. А. Демин, А. В. Белопасова, С. А. Мехряков, О. И. Виноградов, Л. И. Сыромятникова, А. А. Зеньков

Πηγή: Meditsinskiy sovet = Medical Council; № 19 (2021); 16-33 ; Медицинский Совет; № 19 (2021); 16-33 ; 2658-5790 ; 2079-701X

Θεματικοί όροι: легочная артериовенозная мальформация, ESUS, paradoxical embolism, open foramen ovale, atrial septal defect, pulmonary arteriovenous malformation, парадоксальная эмболия, открытое овальное окно, дефект межпредсердной перегородки

Περιγραφή αρχείου: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/6524/5909; Кулеш А.А., Сыромятникова Л.И., Дробаха В.Е., Мехряков С.А., Шестаков В.В. Криптогенный инсульт. М.: ГЭОТАР-Медиа; 2020. 128 с. https://doi.org/10.33029/9704-5597-5-CS-2020-1-128.; Кулеш А.А., Дробаха В.Е., Шестаков В.В. Криптогенный инсульт. Неврология, нейропсихиатрия, психосоматика. 2019;11(4):14–21. https://doi.org/10.14412/2074-2711-2019-4-14-21.; Ntaios G. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week. J Am Coll Cardiol. 2020;75(3):333–340. https://doi.org/10.1016/j.jacc.2019.11.024.; Hart R.G., Diener H.C., Coutts S.B., Easton J.D., Granger C.B., O’Donnell M.J. et al. Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4):429–438. https://doi.org/10.1016/S1474-4422(13)70310-7.; Мехряков С.А., Кулеш А.А., Сыромятникова Л.И., Собянин К.В. Биомаркеры предсердной кардиопатии у пациентов с разными патогенетическими подтипами ишемического инсульта. Неврология, нейропсихиатрия, психосоматика. 2020;12(6):33–41. https://doi.org/10.14412/2074-2711-2020-6-33-41.; Кулеш А.А., Демин Д.А., Виноградов О.И. Криптогенный инсульт. Часть 1: аорто-артериальная эмболия. Медицинский совет. 2021;(4):78–87. https://doi.org/10.21518/2079-701X-2021-4-78-87.; Renna R., Pilato F., Profice P., Della Marca G., Broccolini A., Morosetti R. et al. Risk factor and etiology analysis of ischemic stroke in young adult patients. J Stroke Cerebrovasc Dis. 2014;23(3):e221-e227. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.10.008.; Кулеш А.А., Нуриева Ю.А., Сыромятникова Л.И. Причины ишемического инсульта у пациентов моложе 45 лет: анализ данных регионального сосудистого центра. Неврология, нейропсихиатрия, психосоматика. 2021;13(1):24–30. https://doi.org/10.14412/2074-2711-2021-1-24-30.; Saver J.L., Mattle H.P., Thaler D. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review. Stroke. 2018;49(6):1541–1548. https://doi.org/10.1161/STROKEAHA.117.018153.; Mojadidi M.K., Zaman M.O., Elgendy I.Y., Mahmoud A.N., Patel N.K., Agarwal N. et al. Cryptogenic Stroke and Patent Foramen Ovale. J Am Coll Cardiol. 2018;71(9):1035–1043. https://doi.org/10.1016/j.jacc.2017.12.059.; Кулеш А.А., Шестаков В.В. Открытое овальное окно и эмболический криптогенный инсульт. Неврология, нейропсихиатрия, психосоматика. 2019;11(2):4–11. https://doi.org/10.14412/2074-2711-2019-2-4-11.; Кулеш А.А., Огнерубов Д.В., Мехряков С.А., Меркулов Е.В., Сыромятникова Л.И., Терещенко А.С. и др. Инсульт, ассоциированный с открытым овальным окном: подходы к диагностике и возможности эндоваскулярной профилактики (клинические наблюдения и обзор литературы). Неврология, нейропсихиатрия, психосоматика. 2020;12(2):72–78. https://doi.org/10.14412/2074-2711-2020-2-72-78.; Geva T., Martins J.D., Wald R.M. Atrial septal defects. Lancet. 2014;383(9932):1921–1932. https://doi.org/10.1016/S0140-6736(13)62145-5.; Naqvi N., McCarthy K. P., Ho S.Y. Anatomy of the atrial septum and interatrial communications. J Thorac Dis. 2018;10(24 Suppl.):S2837-S2847. https://doi.org/10.21037/jtd.2018.02.18.; Saric M., Armour A.C., Arnaout M.S., Chaudhry F.A., Grimm R.A., Kronzon I. et al. Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism. J Am Soc Echocardiogr. 2016;29(1):1–42. https://doi.org/10.1016/j.echo.2015.09.011.; Silvestry F.E., Cohen M.S., Armsby L.B., Burkule N.J., Fleishman C.E., Hijazi Z.M. et al. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr. 2015;28(8):910–958. https://doi.org/10.1016/j.echo.2015.05.015.; Ewert P., Berger F., Vogel M., Dähnert I., Alexi-Meshkishvili V., Lange P.E. Morphology of perforated atrial septal aneurysm suitable for closure by transcatheter device placement. Heart. 2000;84(3):327–331. https://doi.org/10.1136/heart.84.3.327.; Nakayama M., Nawa T., Chonan T., Endo K., Morikawa S., Bando M. et al. Prevalence of Pulmonary Arteriovenous Malformations as Estimated by Low-Dose Thoracic CT Screening. Intern Med. 2012;51(13):1677–1681. https://doi.org/10.2169/internalmedicine.51.7305.; Saboo S.S., Chamarthy M., Bhalla S., Park H., Sutphin P., Kay F. et al. Pulmonary arteriovenous malformations: diagnosis. Cardiovasc Diagn Ther. 2018;8(3):325–337. https://doi.org/10.21037/cdt.2018.06.01.; Windecker S., Stortecky S., Meier B. Paradoxical embolism. J Am Coll Cardiol. 2014;64(4):403–415. https://doi.org/10.1016/j.jacc.2014.04.063.; Ozdemir A.O., Tamayo A., Munoz C., Dias B., Spence J.D. Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism. J Neurol Sci. 2008;275(1-2):121–127. https://doi.org/10.1016/j.jns.2008.08.018.; Zietz A., Sutter R., De Marchis G.M. Deep Vein Thrombosis and Pulmonary Embolism Among Patients With a Cryptogenic Stroke Linked to Patent Foramen Ovale-A Review of the Literature. Front Neurol. 2020;11:336. https://doi.org/10.3389/fneur.2020.00336.; Schneider B., Hanrath P., Vogel P., Meinertz T. Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol. 1990;16(4):1000–1009. https://doi.org/10.1016/s0735-1097(10)80354-7.; Мехряков С.А., Кулеш А.А., Сыромятникова Л.И. Ишемический инсульт на фоне вероятного тромбоза insitu в области аневризмы межпредсердной перегородки у пациентки, принимавшей гормональные контрацептивы. Медицинский совет. 2020;(2):132–136. https://doi.org/10.21518/2079-701X-2020-2-132-136.; Nii T., Yoshikawa H., Okabe T., Tachibana I. Septic pulmonary and systemic embolism in tricuspid endocarditis. BMJ Case Rep. 2014;2014:bcr2014206569. https://doi.org/10.1136/bcr-2014-206569.; Cramer S.C., Rordorf G., Maki J.H., Kramer L.A., Grotta J.C., Burgin W.S. et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke. 2004;35(1):46–50. https://doi.org/10.1161/01.STR.0000106137.42649.AB.; DeSimone C. V., Friedman P.A., Noheria A., Patel N.A., DeSimone D. C., Bdeir S. et al. Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiographically detected patent foramen ovale. Circulation. 2013;128(13):1433–1441. https://doi.org/10.1161/CIRCULATIONAHA.113.003540.; Moradi M., Adeli M. Brain abscess as the first manifestation of pulmonary arteriovenous malformation: A case report. Adv Biomed Res. 2014;3:28. https://doi.org/10.4103/2277-9175.124677.; Timon C., Keady C., Murphy C.G. Fat Embolism Syndrome – A Qualitative Review of its Incidence, Presentation, Pathogenesis and Management. Malays Orthop J. 2021;15(1):1–11. https://doi.org/10.5704/MOJ.2103.001; McCarthy C. J., Behravesh S., Naidu S.G., Oklu R. Air Embolism: Practical Tips for Prevention and Treatment. J Clin Med. 2016;5(11):93. https://doi.org/10.3390/jcm5110093.; Meier B., Frank B., Wahl A., Diener H.C. Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis. Eur Heart J. 2012;33(6):705–713b. https://doi.org/10.1093/eurheartj/ehr443.; Koutroulou I., Tsivgoulis G., Tsalikakis D., Karacostas D., Grigoriadis N., Karapanayiotides T. Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review. Front Neurol. 2020;11:281. https://doi.org/10.3389/fneur.2020.00281.; Alsheikh-Ali A.A., Thaler D.E., Kent D.M. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009;40(7):2349–2355. https://doi.org/10.1161/STROKEAHA.109.547828.; Diener H.C., Sacco R.L., Easton J.D., Granger C.B., Bernstein R.A., Uchiyama S. et al.; RE-SPECT ESUS Steering Committee and Investigators. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. N Engl J Med. 2019;380(20):1906–1917. https://doi.org/10.1056/NEJMoa1813959.; Hart R.G., Sharma M., Mundl H., Kasner S.E., Bangdiwala S.I., Berkowitz S.D. et al. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med. 2018;378(23):2191–2201. https://doi.org/10.1056/NEJMoa1802686.; Yetkin E., Atalay H., Ileri M. Atrial septal aneurysm: Prevalence and covariates in adults. Int J Cardiol. 2016;223:656–659. https://doi.org/10.1016/j.ijcard.2016.08.220.; Pearson A.C., Nagelhout D., Castello R., Gomez C.R., Labovitz A.J. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol. 1991;18(5):1223–1229. https://doi.org/10.1016/0735-1097(91)90539-l.; Agmon Y., Khandheria B.K., Meissner I., Gentile F., Whisnant J.P., Sicks J.D. et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation. 1999;99(15):1942–1944. https://doi.org/10.1161/01.cir.99.15.1942.; Cabanes L., Mas J.L., Cohen A., Amarenco P., Cabanes P.A., Oubary P. et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke. 1993;24(12):1865–1873. https://doi.org/10.1161/01.str.24.12.1865.; Elgendy A.Y., Saver J.L., Amin Z., Boudoulas K.D., Carroll J.D., Elgendy I.Y. et al. Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke. AMA Neurol. 2020;77(7):878–886. https://doi.org/10.1001/jamaneurol.2020.0458.; Мехряков C.А., Кулеш А.А., Покаленко Е.А., Сыромятникова Л.И., Куликова С.П., Дробаха В.Е. и др. Феномен парадоксальной эмболии у пациентов с эмболическим криптогенным инсультом. Неврология, нейропсихиатрия, психосоматика. 2020;12(1):13–21. https://doi.org/10.14412/2074-2711-2020-1-13-21.; Ioannidis S.G., Mitsias P.D. Patent Foramen Ovale in Cryptogenic Ischemic Stroke: Direct Cause, Risk Factor, or Incidental Finding? Front Neurol. 2020;11:567. https://doi.org/10.3389/fneur.2020.00567.; Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–1900. https://doi.org/10.1016/s0735-1097(02)01886-7.; Lindsey J.B., Hillis L.D. Clinical update: atrial septal defects in adults. Lancet. 2007;369(9569):1244–1246. https://doi.org/10.1016/S0140-6736(07)60576-5.; Mügge A., Daniel W.G., Angermann C., Spes C., Khandheria B.K., Kronzon I. et al. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation. 1995;91(11):2785–2792. https://doi.org/10.1161/01.cir.91.11.2785.; Bannan A., Shen R., Silvestry F.E., Herrmann H.C. Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism. Catheter Cardiovasc Interv. 2009;74(7):1066–1069. https://doi.org/10.1002/ccd.22170.; Leppert M., Poisson S.N., Carroll J.D. Atrial Septal Defects and Cardioembolic Strokes. Cardiol Clin. 2016;34(2):225–230. https://doi.org/10.1016/j.ccl.2015.12.004.; Gatzoulis M.A., Freeman M.A., Siu S.C., Webb G.D., Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med. 1999;340(11):839–846. https://doi.org/10.1056/NEJM199903183401103.; Berger F., Vogel M., Kramer A., Alexi-Meskishvili V., Weng Y., Lange P.E., Hetzer R. Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg. 1999;68(1): 75–78. https://doi.org/10.1016/s0003-4975(99)00478-6.; Diller G.P., Gatzoulis M.A. Pulmonary vascular disease in adults with congenital heart disease. Circulation. 2007;115(8):1039–1050. https://doi.org/10.1161/CIRCULATIONAHA.105.592386.; Cottin V., Chinet T., Lavolé A., Corre R., Marchand E., Reynaud-Gaubert M. et al. Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia. Medicine (Baltimore). 2007;86(1):1–17. https://doi.org/10.1097/MD.0b013e31802f8da1.; Contegiacomo A., Del Ciello A., Rella R., Attempati N., Coppolino D., Larici A.R. et al. Pulmonary arteriovenous malformations: what the interventional radiologist needs to know. Radiol Med. 2019;124(10): 973–988. https://doi.org/10.1007/s11547-019-01051-7.; Elmali M., Akan H., Findik S., Kale M., Celenk C. Hereditary Hemorrhagic Telangiectasia Associated With Pulmonary Arteriovenous Malformations Presenting as Hemothorax. J Thorac Imaging. 2008;23(4):295–297 https://doi.org/10.1097/RTI.0b013e3181820867.; Hoeper M.M., Krowka M.J., Strassburg C.P. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004;363(9419):1461–1468. https://doi.org/10.1016/S0140-6736(04)16107-2.; Wong H.H., Chan R.P., Klatt R., Faughnan M.E. Idiopathic pulmonary arteriovenous malformations: clinical and imaging characteristics. Eur Respir J. 2011;38(2):368–375. https://doi.org/10.1183/09031936.00075110.; Bosher L.H. Jr, Blake D.A., Byrd B.R. An analysis of the pathologic anatomy of pulmonary arteriovenous aneurysms with particular reference to the applicability of local excision. Surgery. 1959;45(1): 91–104. Available at: https://pubmed.ncbi.nlm.nih.gov/13624986.; Vorselaars V.M., Velthuis S., Snijder R.J., Westermann C.J., Vos J.A., Mager J.J., Post M.C. Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia. Eur Respir J. 2016;47(6): 1750–1757. https://doi.org/10.1183/13993003.01588-2015.; Horner S., Niederkorn K., Gattringer T., Furtner M., Topakian R, Lang W. et al. Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry. J Neurol. 2013;260(1):260–267. https://doi.org/10.1007/s00415-012-6629-9.; Topiwala K.K., Patel S.D., Pervez M., Shovlin C.L., Alberts M.J. Ischemic Stroke in Patients With Pulmonary Arteriovenous Fistulas. Stroke. 2021;52(7):e311-e315. https://doi.org/10.1161/STROKEAHA.120.032073.; Velthuis S., Buscarini E., van Gent M.W. F., Gazzaniga P., Manfredi G., Danesino C. et al. Grade of pulmonary right-to-left shunt on contrast echocardiography and cerebral complications: a striking association. Chest. 2013;144(2):542–548. https://doi.org/10.1378/chest.12-1599.; Pareés I., Horga A., Santamarina E., Mendióroz M., Fernández-Cádenas I., del Río-Espínola A., Alvarez-Sabín J. Stroke after prolonged air travel associated with a pulmonary arteriovenous malformation. J Neurol Sci. 2010;292(1-2):99–100. https://doi.org/10.1016/j.jns.2010.02.019.; Yassi N., Yan B., Dowling R., Mitchell P.J. A rare cause of embolic stroke in hereditary hemorrhagic telangiectasia. J Stroke Cerebrovasc Dis. 2014;23(5):1245–1246. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.07.037.; Zanati Bazan S.G., Braga G.P., Luvizutto G.J., Trindade A.P., PontesNeto O.M., Bazan R. Bihemispheric Paradoxical Cerebral Embolism in a Patient with Pulmonary Thromboembolism and Presumptive Fistula Right-to-Left Shunt. J Stroke Cerebrovasc Dis. 2016;25(6):e95-e97. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.03.038.; Ng P.Y., Ng A.K., Subramaniam B., Burns S.M., Herisson F., Timm F.P. et al. Association of Preoperatively Diagnosed Patent Foramen Ovale With Perioperative Ischemic Stroke. JAMA. 2018;319(5):452–462. https://doi.org/10.1001/jama.2017.21899.; Snijder R.J., Luermans J.G., de Heij A.H., Thijs V., Schonewille W.J., Van De Bruaene A, Swaans M.J. et al. Patent Foramen Ovale With Atrial Septal Aneurysm Is Strongly Associated With Migraine With Aura: A Large Observational Study. J Am Heart Assoc. 2016;5(12):e003771. https://doi.org/10.1161/JAHA.116.003771.; West B.H., Noureddin N., Mamzhi Y., Low C.G., Coluzzi A.C., Shih E.J. et al. Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke. Stroke. 2018;49(5):1123–1128. https://doi.org/10.1161/STROKEAHA.117.020160.; Guchlerner M., Kardos P., Liss-Koch E., Franke J., Wunderlich N., Bertog S., Sievert H. PFO and right-to-left shunting in patients with obstructive sleep apnea. J Clin Sleep Med. 2012;8(4):375–380. https://doi.org/10.5664/jcsm.2026.; Faughnan M.E., Mager J.J., Hetts S.W., Palda V.A., Lang-Robertson K., Buscarini E. et al. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Ann Intern Med. 2020;173(12):989–1001. https://doi.org/10.7326/M20-1443.; Shovlin C.L., Guttmacher A.E., Buscarini E., Faughnan M.E., Hyland R.H., Westermann C.J. et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000;91(1):66–67. https://doi.org/10.1002/(sici)1096-8628(20000306)91:13.0.co;2-p.; Holden V.K., Shah N.G., Verceles A.C. Implications of an Incidental Pulmonary Arteriovenous Malformation. J Investig Med High Impact Case Rep. 2016;4(1):2324709616637190. https://doi.org/10.1177/2324709616637190.; Santamarina E., González-Alujas M.T., Muñoz V., Rovira A., Rubiera M., Ribó M. et al. Stroke patients with cardiac atrial septal abnormalities: differential infarct patterns on DWI. J Neuroimaging. 2006;16(4):334–340. https://doi.org/10.1111/j.1552-6569.2006.00056.x.; Nam K.W., Guk H.S., Kwon H.M., Lee Y.S. Diffusion-Weighted Imaging Patterns According to the Right-to-Left Shunt Amount in Cryptogenic Stroke. Cerebrovasc Dis. 2019;48(1-2):45–52. https://doi.org/10.1159/000502882.; Jauss M., Wessels T., Trittmacher S., Allendörfer J., Kaps M. Embolic lesion pattern in stroke patients with patent foramen ovale compared with patients lacking an embolic source. Stroke. 2006;37(8):2159–2161. https://doi.org/10.1161/01.STR.0000231645.22128.ab.; Hayashida K., Fukuchi K., Inubushi M., Fukushima K., Imakita S., Kimura K. Embolic distribution through patent foramen ovale demonstrated by (99m)Tc-MAA brain SPECT after Valsalva radionuclide venography. J Nucl Med. 2001;42(6):859–863. https://jnm.snmjournals.org/content/42/6/859.long.; Kim J.W., Kim S.J., Yoon C.W., Park C.H., Kang K.W., Kim S.K. et al. Association between the amount of right-to-left shunt and infarct patterns in patients with cryptogenic embolic stroke: a transcranial Doppler study. Int J Stroke. 2013;8(8):657–662. https://doi.org/10.1111/j.1747-4949.2012.00846.x.; Mahmoud A.N., Elgendy I.Y., Agarwal N., Tobis J.M., Mojadidi M.K. Identification and quantification of patent foramen ovale mediated shunts: echocardiography and transcranial Doppler. Interv Cardiol Clin. 2017;6(4):495–504. https://doi.org/10.1016/j.iccl.2017.05.002.; Gutgesell H.P., Huhta J.C., Latson L.A., Huffines D., McNamara D.G. Accuracy of two-dimensional echocardiography in the diagnosis of congenital heart disease. Am J Cardiol. 1985;55(5):514–518. https://doi.org/10.1016/0002-9149(85)90237-1.; Cakmak S., Goldman C., Bozio A., Nighoghossian N., Derex L., Trouillas P. Sinus venosus-type atrial septal defect: a rare curable cause of recurrent transient neurological deficits. Stroke. 2006;37(9):2385–2386. https://doi.org/10.1161/01.STR.0000236635.44539.d4.; Mojadidi M.K., Gevorgyan R., Tobis J.M. A comparison of methods to detect and quantitate PFO: TCD, TTE, ICE and TEE. In: Amin Z., Tobis J.M., Sievert H., Carroll J. (eds.). Patent Foramen Ovale. London: Springer; 2015. pp. 55-65. https://dx.doi.org/10.1007/978-1-4471-4987-3_7.; Mojadidi M.K., Zhang L., Chugh Y., Eshtehardi P., Hovnanians N., Gevorgyan R. et al. Transcranial Doppler: does addition of blood to agitated saline affect sensitivity for detecting cardiac right-to-left shunt? Echocardiography. 2016;33(8):1219–1227. https://doi.org/10.1111/echo.13231.; Fan S., Nagai T., Luo H., Atar S., Naqvi T., Birnbaum Y. et al. Superiority of the combination of blood and agitated saline for routine contrast enhancement. J Am Soc Echocardiogr. 1999;12:94–98. https://doi.org/10.1016/s0894-7317(99)70120-3.; Sun Y.P., Homma S. Patent Foramen Ovale and Stroke. Circ J. 2016;80(8):1665–1673. https://doi.org/10.1253/circj.CJ-16-0534.; Bang O.Y., Lee M.J., Ryoo S., Kim S.J., Kim J.W. Patent Foramen Ovale and Stroke-Current Status. J Stroke. 2015;17(3):229–237. https://doi.org/10.5853/jos.2015.17.3.229.; Porter T.R., Abdelmoneim S., Belcik J.T., McCulloch M. L., Mulvagh S.L., Olson J.J. et al. Guidelines for the Cardiac Sonographer in the Performance of Contrast Echocardiography: A Focused Update from the American Society of Echocardiography. J Am Soc Echocardiogr. 2014;27(8):794–810. https://doi.org/10.1016/j.echo.2014.05.011.; Katsanos A.H., Psaltopoulou T., Sergentanis T.N., Frogoudaki A., Vrettou A.R., Ikonomidis I. et al. Transcranial Doppler versus transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: A systematic review and diagnostic test accuracy meta-analysis. Ann Neurol. 2016;79(4):625–635. https://doi.org/10.1002/ana.24609.; Droste D.W., Lakemeier S., Wichter T., Stypmann J., Dittrich R., Ritter M. et al. Optimizing the technique of contrast transcranial Doppler ultrasound in the detection of right-to-left shunts. Stroke. 2002;33(9):2211–2216. https://doi.org/10.1161/01.str.0000027884.03365.ac.; Hoksbergen A.W., Legemate D.A., Ubbink D.T., Jacobs M.J. Success rate of transcranial color-coded duplex ultrasonography in visualizing the basal cerebral arteries in vascular patients over 60 years of age. Stroke. 1999;30(7):1450–1455. https://doi.org/10.1161/01.str.30.7.1450.; Del Sette M., Dinia L., Rizzi D., Sugo A., Albano B., Gandolfo C. Diagnosis of Right-to-Left Shunt With Transcranial Doppler and Vertebrobasilar Recording; Stroke. 2007;38(8):2254–2256. https://doi.org/10.1161/STROKEAHA.106.479485.; Serena J., Segura T., Perez-Ayuso M.J. Bassaganyas J., Molins A., Dávalos A. The need to quantify right-to-left shunt in acute ischemic stroke: A case-control study. Stroke. 1998;29(7):1322–1328. https://doi.org/10.1161/01.str.29.7.1322.; Белопасова А.В., Добрынина Л.А., Калашникова Л.А., Чечеткин А.О., Каршиева А.Р., Абугов С.А. и др. Легочный артериовенозный шунт – причина рецидивирующих нарушений мозгового кровообращения по механизму парадоксальной эмболии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(9):107–113. https://doi.org/10.17116/jnevro2020120091107.; Majumdar Sh., McWilliams J.P. Approach to pulmonary arteriovenous malformation: A comprehensive update. J Clin Med. 2020;9(6):1927. https://doi.org/10.3390/jcm9061927.; Чечеткин А.О., Каршиева А.Р., Кравченко М.А., Белопасова А.В., Калашникова Л.А., Добрынина Л.А. Легочный артерио-венозный шунт как причина парадоксальной церебральной эмболии: возможности ультразвуковой диагностики. Вестник Российской Военно-медицинской академии. 2019;(S3):162–164. https://doi.org/10.32863/1682-7392-2019-3-67-162-164.; Pristipino C., Sievert H., D’Ascenzo F., Louis Mas J., Meier B., Scacciatella P. et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J. 2019;40(38):3182–3195. https://doi.org/10.1093/eurheartj/ehy649.; Le Moigne E., Timsit S., Ben Salem D., Didier R., Jobic Y., Paleiron N. et al. Patent Foramen Ovale and Ischemic Stroke in Patients With Pulmonary Embolism: A Prospective Cohort Study. Ann Intern Med. 2019;170(11):756–763. https://doi.org/10.7326/M18-3485.; Kim Y.D., Song D., Nam H.S., Lee K., Yoo J., Hong G.R. et al. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale. Thromb Haemost. 2015;114(3):614–622. https://doi.org/10.1160/TH14-12-1040.; Liu K., Song B., Palacios I.F., Inglessis-Azuaje I., Deng W., McMullin D. et al. Patent Foramen Ovale Attributable Cryptogenic Embolism With Thrombophilia Has Higher Risk for Recurrence and Responds to Closure. JACC Cardiovasc Interv. 2020;13(23):2745–2752. https://doi.org/10.1016/j.jcin.2020.09.059.; Salehi Omran S., Hartman A., Zakai N.A., Navi B.B. Thrombophilia Testing After Ischemic Stroke: Why, When, and What?. Stroke. 2021;52(5):1874–1884. https://doi.org/10.1161/STROKEAHA.120.032360.; Deng W., McMullin D., Inglessis-Azuaje I., Locascio J.J., Palacios I.F., Buonanno F.S. et al. Effect of Patent Foramen Ovale Closure After Stroke on Circulatory Biomarkers. Neurology. 2021;97(2):e203-e214. https://doi.org/10.1212/WNL.0000000000012188.; Kent D.M., Saver J.L., Ruthazer R., Furlan A.J., Reisman M., Carroll J.D. et al. Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials. Stroke. 2020;51(10):3119–3123. https://doi.org/10.1161/STROKEAHA.120.029350.; Nakayama R., Takaya Y., Akagi T., Watanabe N., Ikeda M., Nakagawa K. et al. Identification of High-Risk Patent Foramen Ovale Associated With Cryptogenic Stroke: Development of a Scoring System. J Am Soc Echocardiogr. 2019;32(7):811–816. https://doi.org/10.1016/j.echo.2019.03.021.; Elgendy A.Y., Elgendy I.Y., Mojadidi M.K., Mahmoud A.N., Barry J.S., Jneid H. et al. New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials. EuroIntervention. 2019;14(17):1788–1790. https://doi.org/10.4244/eij-d-18-00767.; Varotto L., Bregolin G., Paccanaro M., De Boni A., Bonanno C., Perini F. Network meta-analysis on patent foramen ovale: is a stroke or atrial fibrillation worse?. Neurol Sci. 2021;42(1):101–109. https://doi.org/10.1007/s10072-020-04922-4.; Огнерубов Д.В., Терещенко А.С., Самко А.Н., Арутюнян Г.К., Сивакова О.А., Певзнер Д.В. и др. Безопасность и эффективность эндоваскулярного закрытия открытого овального окна: первые результаты российского многоцентрового исследования. Неврология, нейропсихиатрия, психосоматика. 2020;12(6):26–32. https://doi.org/10.14412/2074-2711-2020-6-26-32.; Wintzer-Wehekind J., Alperi A., Houde C., Côté J.M., Asmarats L., Côté M., Rodés-Cabau J. Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism. J Am Coll Cardiol. 2019;73(3):278–287. https://doi.org/10.1016/j.jacc.2018.10.061.; Deng W., Yin S., McMullin D., Inglessis-Azuaje I., Elmariah S., Hung J. et al. Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence: A Prospective Cohort Study. Ann Intern Med. 2020;172(11):717–725. https://doi.org/10.7326/M19-3583.; Hoffmann A., Chockalingam P., Balint O.H., Dadashev A., Dimopoulos K., Engel R. et al. Cerebrovascular accidents in adult patients with congenital heart disease. Heart. 2010;96:1223–1226. https://doi.org/10.1136/hrt.2010.196147.; Nyboe C., Olsen M.S., Nielsen-Kudsk J.E., Hjortdal V.E. Atrial fibrillation and stroke in adult patients with atrial septal defect and long-term effect of closure. Heart. 2015;101:706–711. https://doi.org/10.1136/heartjnl-2014-306552.; Angelini F., Fortuni F., Tsivgoulis G., Agnelli G., Bocchino P.P., Franchin L. et al. Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis. Cardiovasc Drugs Ther. 2021;35(5):987–993. https://doi.org/10.1007/s10557-020-07068-9.; Бобров Е.И. Артериовенозные фистулы лёгких: диагностика и эндоваскулярное лечение. Региональное кровообращение и микроциркуляция. 2003;2(3):11–16. Режим доступа: https://elibrary.ru/item.asp?id=13074540.; Pereira-da-Silva T., Martins J.D., de Sousa L., Fiarresga A., Trigo Pereira C., Cruz Ferreira R., Ferreira Pinto F. Percutaneous occlusion of vascular malformations in pediatric and adult patients: 20-year experience of a single center. Catheter Cardiovasc Interv. 2016;87(2):E62-E68. https://doi.org/10.1002/ccd.26220.; Noble S., Perren F., Roffi M. Cryptogenic stroke with right-to-left shunt and no patent foramen ovale. Arch Cardiovasc Dis. 2014;107(6-7):418–419. https://doi.org/10.1016/j.acvd.2012.07.004.; Barbaryan A., Bailuc S., Raqeem M.W., Kak M., Derani L., Mirrakhimov A.E. Wake-Up Call: Pulmonary Arteriovenous Malformation. Am J Med. 2017;130(3):290–292. https://doi.org/10.1016/j.amjmed.2016.10.021.; Patti G., D’Antonio L., Sedati P., Mega S., Di Sciascio G. Percutaneous closure of a pulmonary arteriovenous malformation in young patient with cryptogenic stroke. JACC CardiovascInterv. 2013;6(5):e26-e27. https://doi.org/10.1016/j.jcin.2012.11.016.; Ishikawa Y., Yamanaka K., Nishii T., Fujii K., Rino Y., Maehara T. Videoassisted thoracoscopic surgery for pulmonary arteriovenous malformations: report of five cases. Gen Thorac Cardiovasc Surg. 2008;56(4):187–190. https://doi.org/10.1007/s11748-007-0215-6.; Nakamura H., Miwa K., Haruki T., Adachi Y., Fujioka S., Taniguchi Y. Pulmonary arteriovenous fistula with cerebral infarction successfully treated by video-assisted thoracic surgery. Ann Thorac Cardiovasc Surg. 2008;14(1):35–37. Available at: https://pubmed.ncbi.nlm.nih.gov/18292739/; Faughnan M., Palda V., Garcia-Tsao G., Geisthoff U., McDonald J., Proctor D. et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011;48:73–87. https://doi.org/10.1136/jmg.2009.069013.; Devlin H.L., Hosman A.E., Shovlin C.L. Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia. N Engl J Med. 2013;368(9):876–878. https://doi.org/10.1056/NEJMc1213554.; Shovlin C.L., Millar C.M., Droege F., Kjeldsen A., Manfredi G., Suppressa P. et al. Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2019;14(1):210. https://doi.org/10.1186/s13023-019-1179-1.; Kleindorfer D.O., Towfighi A., Chaturvedi S., Cockroft K.M., Gutierrez J., Lombardi-Hill D. et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association / American Stroke Association. Stroke. 2021;52(7):e364-e467. https://doi.org/10.1161/STR.0000000000000375.; Baumgartner H., De Backer J., Babu-Narayan S.V., Budts W., Chessa M., Diller G.P. et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563–645. https://doi.org/10.1093/eurheartj/ehaa554.; Shovlin C.L., Condliffe R., Donaldson J.W., Kiely D.G., Wort S.J. British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations. Thorax. 2017;72(12):1154–1163. https://doi.org/10.1136/thoraxjnl-2017-210764.

Διαθεσιμότητα: https://www.med-sovet.pro/jour/article/view/6524
https://doi.org/10.21518/2079-701X-2021-19-16-33

Открытое овальное окно и эмболический криптогенный инсульт

Πηγή: Неврология, нейропсихиатрия, психосоматика, Vol 0, Iss 0 (2020)

Θεματικοί όροι: открытое овальное окно, парадоксальная эмболия, криптогенный инсульт, окклюзия, Neurology. Diseases of the nervous system, RC346-429

Περιγραφή αρχείου: electronic resource

Relation: https://nnp.ima-press.net/nnp/article/view/980; https://doaj.org/toc/2074-2711; https://doaj.org/toc/2310-1342

Σύνδεσμος πρόσβασης: https://doaj.org/article/b8d6c1c593c24e678fbf01cb1487b8f6

Patent foramen ovale-related stroke: diagnostic approaches and the possibility of endovascular prophylaxis (clinical cases and literature review) ; Инсульт, ассоциированный с открытым овальным окном: подходы к диагностике и возможности эндоваскулярной профилактики (клинические наблюдения и обзор литературы)

Συγγραφείς: A. A. Kulesh, D. V. Ognerubov, S. A. Mekhryakov, E. V. Merkulov, L. I. Syromyatnikova, A. S. Tereshchenko, A. N. Samko, V. V. Shestakov, Yu. V. Karakulova, А. А. Кулеш, Д. В. Огнерубов, С. А. Мехряков, Е. В. Меркулов, Л. И. Сыромятникова, А. С. Терещенко, А. Н. Самко, В. В. Шестаков, Ю. В. Каракулова

Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 12, No 2 (2020); 72-78 ; Неврология, нейропсихиатрия, психосоматика; Vol 12, No 2 (2020); 72-78 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2020-2

Θεματικοί όροι: профилактика, cryptogenic stroke, paradoxical embolism, endovascular occlusion, prevention, криптогенный инсульт, парадоксальная эмболия, эндоваскулярная окклюзия

Περιγραφή αρχείου: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/1307/1030; Giblett J, Abdul-Samad O, Shapiro L, et al. Patent Foramen Ovale Closure in 2019. Interv Cardiol. 2019 Feb;14(1):34-41. doi:10.15420/icr.2018.33.2.; Кулеш АА, Шестаков ВВ. Открытое овальное окно и эмболический криптогенный инсульт. Неврология, нейропсихиатрия, психосоматика. 2019;11(2):4-11. doi:10.14412/2074-2711-2019-2-4-11; Ozdemir AO, Tamayo A, Munoz C, et al. Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism. J Neurol Sci. 2008 Dec 15;275(1-2):121-7. doi:10.1016/j.jns.2008.08.018. Epub 2008 Sep 26.; Ryoo S, Chung JW, Lee MJ, et al. An Approach to Working Up Cases of Embolic Stroke of Undetermined Source. J Am Heart Assoc. 2016 Mar 22;5(3):e002975. doi:10.1161/JAHA.115.002975.; Nam KW, Guk HS, Kwon HM, Lee YS. Diffusion-Weighted Imaging Patterns According to the Right-to-Left Shunt Amount in Cryptogenic Stroke. Cerebrovasc Dis. 2019;48(1-2):45-52. doi:10.1159/000502882. Epub 2019 Sep 6.; Pristipino C, Sievert H, D'Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. EuroIntervention. 2019 Jan 20;14(13): 1389-1402. doi:10.4244/EIJ-D-18-00622.; Кулеш АА, Дробаха ВЕ, Шестаков ВВ. Криптогенный инсульт. Неврология, нейропсихиатрия, психосоматика. 2019;11(4): 14-21. doi:10.14412/2074-2711-2019-4-14-21; Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988 May 5;318(18): 1148-52.; Webster MW, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet. 1988 Jul 2;2(8601):11-2.; Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation. 2005 Aug 16; (7):1063-72.; Di Tullio MR, Sacco RL, Sciacca RR, et al. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007 Feb 20;49(7):797-802. Epub 2007 Feb 5.; Furlan AJ, Reisman M, Massaro J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012 Mar 15;366(11):991-9. doi:10.1056/NEJMoa1009639.; Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013 Mar 21;368(12):1092-100. doi:10.1056/NEJMoa1301440.; Meier B, Kalesan B, Mattle HP, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013 Mar 21;368(12):1083-91. doi:10.1056/NEJMoa1211716.; Mas JL, Derumeaux G, Guillon B, et al; CLOSE Investigators. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017 Sep 14;377(11): 1011-1021. doi:10.1056/NEJMoa1705915.; S∅ndergaard L, Kasner SE, Rhodes JF, et al; Gore REDUCE Clinical Study Investigators. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017 Sep 14;377(11):1033-1042. doi:10.1056/NEJMoa1707404.; Lee PH, Song JK, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO Trial. J Am Coll Cardiol. 2018 May 22;71(20):2335-2342. doi:10.1016/j.jacc.2018.02.046. Epub 2018 Mar 12.; Ekker MS, Boot EM, Singhal AB, et al. Epidemiology, aetiology and management of ischaemic stroke in young adults. Lancet Neurol. 2018 Sep;17(9):790-801. doi:10.1016/S1474-4422(18)30233-3.; Singhal AB, Biller J, Elkind MS, et al. Recognition and management of stroke in young adults and adolescents. Neurology. 2013 Sep 17;81(12):1089-97. doi:10.1212/WNL.0b013e3182a4a451. Epub 2013 Aug 14.; Quenardelle V, Lauer-Ober V, Zinchenko I, et al. Stroke Mimics in a Stroke Care Pathway Based on MRI Screening. Cerebrovasc Dis. 2016;42(3-4):205-12. doi:10.1159/000445956. Epub 2016 Apr 26.; Калашникова ЛА, Добрынина ЛА. Ишемический инсульт в молодом возрасте. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017;117(8):3-12.; Sun YP, Homma S. Patent Foramen Ovale and Stroke. Circ J. 2016 Jul 25;80(8):1665-73. doi:10.1253/circj.CJ-16-0534. Epub 2016 Jun 22.; Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009 Jul;40(7):2349-55. doi:10.1161/STROKEAHA.109.547828. Epub 2009 May 14.; West BH, Noureddin N, Mamzhi Y, et al. Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke. Stroke. 2018 May;49(5):1123-1128. doi:10.1161/STROKEAHA.117.020160. Epub 2018 Apr 10.; Калашникова ЛА. Диссекция внутренних сонных и позвоночных артерий: клиника, диагностика лечение. Неврология, нейропсихиатрия, психосоматика. 2013;5(2S):40-5. doi:10.14412/2074-2711-2013-2357; Mojadidi MK, Bokhoor PI, Gevorgyan R, et al. Sleep apnea in patients with and without a right-to-left shunt. J Clin Sleep Med. 2015 Nov 15;11(11):1299-304. doi:10.5664/jcsm.5190.; Saver JL, Mattle HP, Thaler D. Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review. Stroke. 2018 Jun;49(6):1541-1548. doi:10.1161/STROKEAHA.117.018153. Epub 2018 May 14.; Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013 Aug 13;81(7):619-25. doi:10.1212/WNL.0b013e3182a08d59. Epub 2013 Jul 17.; Nakayama R, Takaya Y, Akagi T, et al. Identification of High-Risk Patent Foramen Ovale Associated With Cryptogenic Stroke: Development of a Scoring System. J Am Soc Echocardiogr. 2019 Jul;32(7):811-816. doi:10.1016/j.echo.2019.03.021. Epub 2019 May 23.; Wintzer-Wehekind J, Alperi A, Houde C, et al. Impact of Discontinuation of Antithrombotic Therapy Following Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism. Am J Cardiol. 2019 May 1;123(9):1538-1545. doi:10.1016/j.amjcard.2019.01.043. Epub 2019 Feb 8.; Wintzer-Wehekind J, Alperi A, Houde C et al. Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism. J Am Coll Cardiol. 2019 Jan 29;73(3):278-287. doi:10.1016/j.jacc.2018.10.061.; Hviid CVB, Simonsen CZ, Hvas AM. Recurrence Risk in Patients with Cryptogenic Stroke, Patent Foramen Ovale, and Thrombophilia: A Systematic Review and Meta-Analysis. Thromb Haemost. 2019 Nov; 119(11):1839-1848. doi:10.1055/s-0039-1693739. Epub 2019 Aug 4.

Διαθεσιμότητα: https://nnp.ima-press.net/nnp/article/view/1307
https://doi.org/10.14412/2074-2711-2020-2-72-78

Ischemic stroke on the background of probable in situ thrombosis of atrial septal aneurysm in a patient taking hormonal contraceptives ; Ишемический инсульт на фоне вероятного тромбоза in situ в области аневризмы межпредсердной перегородки у пациентки, принимавшей гормональные контрацептивы

Συγγραφείς: S. A. Mekhryakov, A. A. Kulesh, L. I. Syromyatnikova, С. А. Мехряков, А. А. Кулеш, Л. И. Сыромятникова

Πηγή: Meditsinskiy sovet = Medical Council; № 2 (2020); 132-136 ; Медицинский Совет; № 2 (2020); 132-136 ; 2658-5790 ; 2079-701X ; 10.21518/2079-701X-2020-2

Θεματικοί όροι: эхокардиография, cardioembolic stroke, atrial septal aneurysm, paradoxical embolism, echocardiography, кардиоэмболический инсульт, аневризма межпредсердной перегородки, парадоксальная эмболия

Περιγραφή αρχείου: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/5530/5040; Silver M.D., Dorsey J.S. Aneurysms of the septum primum in adults. Arch Pathol Lab Med. 1978;102(2):62–65. Available at: https://www.ncbi.nlm.nih.gov/pubmed/579965.; Schneider B., Haurath P., Vogel P., Meinertz T. Improved morphologic characterization of atrial septal aneurysm by transoesophageal echocardiography: Relation to cerebrovascular events. J Am Coll Cardiol. 1990;16(4):1000– 1009. doi:10.1016/s0735-1097(10)80354-7.; Grosgogeat Y., Lhermitte F., Carpentier A., Facquet J., Alhomme P., Tran T. Aneurysm of the interauricular septum revealed by a cerebral embolism. Arch Mal Coeur Vaiss. 1973;66(2):169–177.; Chammas E., Trinca M., Goullard L. et al. Multiple cerebral infarcts associated with an atrial septal aneurysm. Superimposed thrombus detected by transesophageal echocardiography. Angiology. 1995;46(4):327–331. doi:10.1177/000331979504600407.; Belkin R.N., Welish S.J., Figueroa R. et al. Atrial-septal-aneurysm-associated thrombus and stroke: Demonstration with transesophageal echocardiography. J Stroke Cerebrovasc Dis. 1991;1(3):142–145. doi:10.1016/S10523057(10)80006-0.; Adauy J.V., Gabrielli L., Córdova S., Saavedra R., McNab P. . Big thrombus «sitting» in an atrial septal aneurysm. Echocardiography. 2017;34(9):1396–1398. doi:10.1111/echo.13574.; Hashimoto Y., Terasaki T., Hara Y., Yonehara T., Uchino M. Cerebral embolism due to lone atrial septal aneurysm. Rinsho Shinkeigaku. 1997;37(9):851–853. Available at: https://www.ncbi.nlm.nih.gov/pubmed/9431004.; Belotti G., Fragasso G., Pizzetti G., Chierchia S. An aneurysm of the interatrial septum and cerebral embolic events: a clinical case and review of the literature. G Ital Cardiol. 1993;23(9):915–920. Available at: https://www.ncbi.nlm.nih.gov/pubmed/8119521.; Hoerauf K., Bein T., Muscholl M., Held P., Holzschuh M., Taeger K. Atrial septum aneurysm as the cause of a thromboembolic infarction of the brain stem and cerebellum?Dtsch Med Wochenschr. 1993;118(34/35):1236–1240. doi:10.1055/s-2008-1059448.; Di Pasquale G., Andreoli A., Grazi P. Dominici P., Pinelli G. Cardioembolic stroke from atrial septal aneurysm. Stroke. 1988;19(5):640–643. doi:10.1161/01.str.19.5.640.; Razaq M., Parihar R.K., Saini G. Atrial septal aneurysm and stroke. Ann Pediatr Cardiol. 2012;5(1):98–99. doi:10.4103/09742069.93726.; Cianciulli T.F., Chejtman D., Lipshitz S.B., Saccheri M.C., Dethinne S.L., Prezioso H.A. Atrial septal aneurysm and spontaneous echo contrast: an association with higher embolic risk? Eur J Echocardiogr. 2006;7(3):243–246. doi:10.1016/j.euje.2005.04.004.; Tokunaga K., Yasaka M., Kuwashiro T. et al. Association between the maximal distance of atrial septal protrusion and cryptogenic stroke. Int J Stroke. 2017;12(9):941–945. doi:10.1177/1747493016685721.

Διαθεσιμότητα: https://www.med-sovet.pro/jour/article/view/5530
https://doi.org/10.21518/2079-701X-2020-2-132-136

Открытое овальное окно и эмболический криптогенный инсульт

Πηγή: Неврология, нейропсихиатрия, психосоматика, Vol 0, Iss 0 (2020)

Θεματικοί όροι: открытое овальное окно, парадоксальная эмболия, криптогенный инсульт, окклюзия, Neurology. Diseases of the nervous system, RC346-429

Relation: https://nnp.ima-press.net/nnp/article/view/980; https://doaj.org/toc/2074-2711; https://doaj.org/toc/2310-1342; https://doaj.org/article/b8d6c1c593c24e678fbf01cb1487b8f6

Διαθεσιμότητα: https://doaj.org/article/b8d6c1c593c24e678fbf01cb1487b8f6

Etiology of Cryptogenic Stroke ; Этиология криптогенного инсульта

Συγγραφείς: G. R. Ramazanov, T. A. Magomedov, L. T. Khamidova, N. V. Rybalko, S. S. Petrikov, N. A. Shamalov, Г. Р. Рамазанов, Т. А. Магомедов, Л. Т. Хамидова, Н. В. Рыбалко, С. С. Петриков, Н. А. Шамалов

Πηγή: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 8, № 3 (2019); 302-314 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 8, № 3 (2019); 302-314 ; 2541-8017 ; 2223-9022 ; 10.23934/2223-9022-2019-8-3

Θεματικοί όροι: атерома аорты, paradoxical embolism, open oval window, Fabry disease, aortic atheroma, парадоксальная эмболия, открытое овальное окно, болезнь Фабри

Περιγραφή αρχείου: application/pdf

Relation: https://www.jnmp.ru/jour/article/view/691/689; https://www.jnmp.ru/jour/article/view/691/709; Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41. PMID: 7678184 https://doi.org/10.1161/01.str.24.1.35; Putaala J, Nieminen T, Haapaniemi E, Meretoja A, Rantanen K, Heikkinen N, et al. Undetermined stroke with an embolic pattern — a common phenotype with high early recurrence risk. Ann Med. 2015;47(5):406–413. PMID: 262242000 https://doi.org/10.3109/07853890.2015.1057612; Li L, Yiin GS, Geraghty OC, Schulz UG, Kuker W, Mehta Z, et al. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol. 2015;14(9):903–913. PMID: 26227434 https://doi.org/10.1016/S1474-4422(15)00132-5; Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009;40(4):1195–1203. PMID: 19246709 https://doi.org/10.1161/STROKEAHA.108.529883; Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. Stroke Data Bank: design, methods, and baseline characteristics. Stroke. 1988;19(5):547– 554. PMID: 3363589 https://doi.org/10.1161/01.str.19.5.547; Kunitz SC, Gross CR, Heyman A, Kase CS, Mohr JP, Price TR, et al. The pilot Stroke Data Bank: definition, design, and data. Stroke. 1984;15(4):740–746. PMID: 6464070 https://doi.org/10.1161/01.str.15.4.740; Perera KS, Vanassche T, Bosch J, Swaminathan B, Mundl H, Giruparajah M, et al. Global Survey of the Frequency of Atrial Fibrillation-Associated Stroke: Embolic Stroke of Undetermined Source Global Registry. Stroke. 2016;47(9):2197–2202. PMID: 27507860 https://doi.org/10.1161/STROKEAHA.116.013378; Bal S, Patel SK, Almekhlafi M, Modi J, Demchuk AM, Coutts SB. High Rate of Magnetic Resonance Imaging Stroke Recurrence in Cryptogenic Transient Ischemic Attack and Minor Stroke Patients. Stroke. 2012;43(12):3387–3388. PMID: 23033345 https://doi.org/10.1161/STROKEAHA.112.671172; Bang OY, Lee PH, Joo SY, Lee JS, Joo IS, Huh K. Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann Neurol. 2003;54(2):227–234. PMID: 12891675 https://doi.org/10.1002/ana.10644; Ntaios G, Papavasileiou V, Milionis H, Makaritsis K, Vemmou A, Koroboki E, et al. Embolic Strokes of Undetermined Source in the Athens Stroke Registry: An Outcome Analysis. Stroke. 2015;46(8):2087–2093. PMID: 26159795 https://doi.org/10.1161/STROKEAHA.115.009334; Choe WC, Passman RS, Brachmann J, Morillo CA, Sanna T, Bernstein RA, et al. A Comparison of Atrial Fibrillation Monitoring Strategies After Cryptogenic Stroke (from the Cryptogenic Stroke and Underlying AF Trial). Am J Cardiol. 2015;116(6):889–893. PMID: 26183793 https://doi.org/10.1016/j.amjcard.2015.06.012; Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation. 1999; 99(9): 999– 1004. PMID: 10051291 https://doi.org/10.1161/01.cir.99.8.999; Rojo-Martinez E, Sandín-Fuentes M, Calleja-Sanz AI, Cortijo-García E, García-Bermejo P, Ruiz-Piñero M, et al. High performance of an implantable Holter monitor in the detection of concealed paroxysmal atrial fibrillation in patients with cryptogenic stroke and a suspected embolic mechanism. Rev Neurol. 2013;57(6):251–257. PMID: 24008935; Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478–2486. PMID: 24963567 https://doi.org/10.1056/NEJMoa1313600; Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, et al. Atrial Fibrillation in Patients with Cryptogenic Stroke. N Engl J Med. 2014;370(26):2467–2477. PMID: 24963566 https://doi.org/10.1056/NEJMoa1311376; Lethen H, Flachskampf FA, Schneider R, Sliwka U, Köhn G, Noth J, et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol. 1997;80(8):1066–1069. PMID: 9352979 https://doi.org/10.1016/s00029149(97)00604-8; Kamel H, Elkind MS, Bhave PD, Navi BB, Okin PM, Iadecola C, et al. Paroxysmal supraventricular tachycardia and the risk of ischemic stroke. Stroke. 2013;44(6):1550–1554. PMID: 23632982 https://doi.org/10.1161/STROKEAHA.113.001118; Tanne D, D’Olhaberriague L, Trivedi AM, Salowich-Palm L, Schultz LR, Levine SR. Anticardiolipin antibodies and mortality in patients with ischemic stroke: a prospective follow-up study. Neuroepidemiology. 2002;21(2):93–99. PMID: 11901279 https://doi.org/10.1159/000048623; Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C, et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014;129(21):2094–2099. PMID: 24633881 https://doi.org/10.1161/CIRCULATIONAHA.113.007825; Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the trends study. Circ Arrhythm Electrophysiol. 2009;2(5):474–480. PMID: 19843914 https://doi.org/10.1161/CIRCEP.109.849638; Keach JW, Bradley SM, Turakhia MP, Maddox TM. Early detection of occult atrial fibrillation and stroke prevention. Heart. 2015;101(14):1097– 1102. PMID: 25935765 https://doi.org/10.1136/heartjnl-2015-307588; Bernstein RA, Di Lazzaro V, Rymer MM, Passman RS, Brachmann J, Morillo CA, et al. Infarct topography and detection of atrial fibrillation in cryptogenic stroke: results from CRYSTAL AF. Cerebrovasc Dis. 2015;40(12):91–96. PMID: 26182860 https://doi.org/10.1159/000437018; Favilla CG, Ingala E, Jara J, Fessler E, Cucchiara B, Messé SR, et al. Predictors of finding occult atrial fibrillation after cryptogenic stroke. Stroke. 2015;46(5):1210–1215. PMID:25851771 https://doi.org/10.1161/STROKEAHA.114.007763; Miller DJ, Khan MA, Schultz LR, Simpson JR, Katramados AM, Russman AN, et al. Outpatient cardiac telemetry detects a high rate of atrial fibrillation in cryptogenic stroke. J Neurol Sci. 2013;324(1–2):57–61. PMID: 23102659 https://doi.org/10.1016/j.jns.2012.10.001; Kamel H, Soliman EZ, Heckbert SR, Kronmal RA, Longstreth WT Jr, Nazarian S, et al. P-wave morphology and the risk of incident ischemic stroke in the Multi-Ethnic Study of Atherosclerosis. Stroke. 2014;45(9):2786–2788 PMID: 25052322 https://doi.org/10.1161/STROKEAHA.114.006364; Yaghi S, Moon YP, Mora-McLaughlin C, Willey JZ, Cheung K, Di Tullio MR, et al. Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke. 2015;46(6):1488–1493 PMID: 25908460 https://doi.org/10.1161/STROKEAHA.115.008711; Yaghi S, Boehme AK, Hazan R, Hod EA, Canaan A, Andrews HF, et al. Atrial cardiopathy and cryptogenic stroke: a cross-sectional pilot study. J Stroke Cerebrovasc Dis. 2015;25(1):110–114. PMID: 26476588 https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.09.001; Sinner MF, Stepas KA, Moser CB, Krijthe BP, Aspelund T, Sotoodehnia N, et al. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF consortium of community-based cohort studies. Europace. 2014;16(10):1426–1433. PMID: 25037055 https://doi.org/10.1093/europace/euu175; Llombart V, Antolin-Fontes A, Bustamante A, Giralt D, Rost NS, Furie K, et al. B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis. Stroke. 2015;46(5):1187–1189. PMID: 25765726 https://doi.org/10.1161/STROKEAHA.114.008311; Yaghi S, Elkind MS. Cryptogenic stroke: a diagnostic challenge. Neurol Clin Pract. 2014;4(5):386–393. PMID: 25317376 https://doi.org/10.1212/CPJ.0000000000000086; De Bruijn SF, Agema WR, Lammers GJ, van der Wall EE, Wolterbeek R, Holman ER, et al. Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke. 2006;37(10):2531–2534. PMID: 16946152 https://doi.org/10.1161/01.STR.0000241064.46659.69; Srichai MB, Junor C, Rodriguez LL, Stillman AE, Grimm RA, Lieber ML, et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J. 2006;152(1):75–84. PMID: 16824834 https://doi.org/10.1016/j.ahj.2005.08.021; Barkhausen J, Hunold P, Eggebrecht H, Schüler WO, Sabin GV, Erbel R, et al. Detection and characterization of intracardiac thrombi on MR imaging. AJR Am J Roentgenol. 2002;179(6):1539–1544. PMID: 12438051 https://doi.org/10.2214/ajr.179.6.1791539; Bahrer A, Mowla A, Kodali S, Polsani VR, Nabi F, Nagueh SF, et al. Cardiac MRI improves identification of etiology of acute ischemic stroke. Cerebrovasc Dis. 2014;37(4):277–284. PMID: 24819735 https://doi.org/10.1159/000360073; Fisher CM. Occlusion of the internal carotid artery. Arch Neurol Psychiatry. 1951;65(5):346–377. PMID: 13418970; Saam T, Underhill HR, Chu B, Takaya N, Cai J, Polissar NL, et al. Prevalence of American Heart Association type VI carotid atherosclerotic lesions identified by magnetic resonance imaging for different levels of stenosis as measured by duplex ultrasound. J Am Coll Cardiol. 2008;51(10):1014– 1021. PMID: 18325441 https://doi.org/10.1016/j.jacc.2007.10.054; Freilinger TM, Schindler A, Schmidt C, Grimm J, Cyran C, Schwarz F, et al. Prevalence of Nonstenosing, Complicated Atherosclerotic Plaques in Cryptogenic Stroke. JACC Cardiovasc Imaging. 2012;5(4):397–405. PMID: 22498329 https://doi.org/10.1016/j.jcmg.2012.01.012; Winter WJ Jr. Atheromatous emboli; a cause of cerebral infarction; report of two cases. AMA Arch Pathol. 1957;64(2):137–142. PMID: 13443604; Di Tullio MR, Sacco RL, Gersony D, Nayak H, Weslow RG, Kargman DE, et al. Aortic atheromas and acute ischemic stroke: A transesophageal echocardiographic study in an ethnically mixed population. Neurology. 1996;46(6):1560–1566. PMID: 8649549 https://doi.org/10.1212/wnl.46.6.1560; Amarenco P, Duyckaerts C, Tzourio C, Hénin D, Bousser MG, Hauw JJ. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med. 1992;326:221. PMID: 1727976 https://doi.org/10.1056/NEJM199201233260402; Knebel F, Masuhr F, von Hausen W, Walde T, Dreger H, Raab V, et al. Transesophageal echocardiography in patients with cryptogenic cerebral ischemia. Cardiovasc Ultrasound. 2009;7:15. PMID: 19327171 https://doi.org/10.1186/1476-7120-7-15; Okuma H, Kitagawa Y, Yasuda T, Tokuoka K, Takagi S. Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome. Int J Med Sci. 2009;7(1):15– 18. PMID: 20046230 https://doi.org/10.7150/ijms.7.15; Rundek T, Di Tullio MR, Sciacca RR, Titova IV, Mohr JP, Homma S, et al. Association between large aortic arch atheromas and high-intensity transient signals in elderly stroke patients. Stroke. 1999;30(12):2683– 2686. PMID: 10582997 https://doi.org/10.1161/01.str.30.12.2683; The French Study of Aortic Plaques in Stroke Group; Amarenco P, Cohen A, Hommel M. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med. 1996;334(19):1216–1221. PMID: 8606716 https://doi.org/10.1056/NEJM199605093341902; Stone DA, Hawke MW, LaMonte M, Kittner SJ, Acosta J, Corretti M, et al. Ulcerated atherosclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: a multiplane transesophageal echocardiographic study. Am Heart J. 1995;130(1):105–108. PMID: 7611098 https://doi.org/10.1016/0002-8703(95)90243-0; Di Tullio MR, Russo C, Jin Z, Sacco RL, Mohr JP, Homma S. Aortic arch plaques and risk of recurrent stroke and death. Circulation. 2009;119(17):2376–2382. PMID: 19380621 https://doi.org/10.1161/CIRCULATIONAHA.108.811935; Kamel H, Gialdini G, Baradaran H, Giambrone AE, Navi BB, Lerario MP, et al. Cryptogenic Stroke and Nonstenosing Intracranial Calcified Atherosclerosis. J Stroke Cerebrovasc Dis. 2017;26(4):863–870. PMID: 27887791 https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.10.035; Huang YN, Gao S, Li SW, Huang Y, Li JF, Wong KS, et al. Vascular lesions in Chinese patients with transient ischemic attacks. Neurology. 1997;48(2):524–525. PMID: 9040750 https://doi.org/10.1212/wnl.48.2.524; Weber R, Kraywinkel K, Diener HC, Weimar C. Symptomatic intracranial atherosclerotic stenoses: prevalence and prognosis in patients with acute cerebral ischemia. Cerebrovasc Dis. 2010;30(2):188–193. PMID: 20588014 https://doi.org/10.1159/000317107; Cohnheim J. Vorlesungen über allgemeine Pathologie. Ein Handbuch für Arzte und Studierende. Berlin: Hirschwald, 1878.; Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002;105(22):2625–2631. PMID: 12045168 https://doi.org/10.1161/01.cir.0000017498.88393.44; Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke incidental or pathogenic? Stroke. 2009;40(7):2349–2355. PMID: 19443800 https://doi.org/10.1161/STROKEAHA.109.547828; Hamedani AG, Cole JW, Mitchell BD, Kittner SJ. Meta-analysis of factor V Leiden and ischemic stroke in young adults: the importance of case ascertainment. Stroke. 2010;41(8):1599–1603. PMID: 20616326 https://doi.org/10.1161/STROKEAHA.110.581256; Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000;55(8):1172– 1179. PMID: 11071496 https://doi.org/10.1212/wnl.55.8.1172; Wessler BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind MS, et al. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging. 2014;7(1):125–131. PMID: 24214884 https://doi.org/10.1161/CIRCIMAGING.113.000807; Liberman AL, Daruwalla VJ, Collins JD, Maas MB, Botelho MP, Ayache JB, et al. Diagnostic yield of pelvic magnetic resonance venography in patients with cryptogenic stroke and patent foramen ovale. Stroke. 2014;45(8):2324–2329. PMID: 24938843 https://doi.org/10.1161/STROKEAHA.114.005539; Osgood M, Budman E, Carandang R, Goddeau RP Jr, Henninger N. Prevalence of pelvic vein pathology in patients with cryptogenic stroke and patent foramen ovale undergoing MRV pelvis. Cerebrovasc Dis. 2015;39(3–4):216–223. PMID: 257917 https://doi.org/10.1159/000376613; Cramer SC, Rordorf G, Maki JH, Kramer LA, Grotta JC, Burgin WS, et al. Increased pelvic vein thrombi in cryptogenic stroke results of the Paradoxical Emboli From Large Veins in Ischemic Stroke (PELVIS) Study. Stroke. 2004;35(1):46–50. PMID: 14657451 https://doi.org/10.1161/01.STR.0000106137.42649.AB; Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013;81(7):619–625. PMID: 23864310 https://doi.org/10.1212/WNL.0b013e3182a08d59; Loscalzo J. Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options. Am Heart J. 1986;112(1):141–145. PMID: 3728270; Tanislav C, Puille M, Pabst W, Reichenberger F, Grebe M, Nedelmann M, et al. High Frequency of Silent Pulmonary Embolism in Patients With Cryptogenic Stroke and Patent Foramen Ovale. Stroke. 2011;42(3):822– 824. PMID: 21257827 https://doi.org/10.1161/STROKEAHA.110.601575; Wu LA, Malouf JF, Dearani JA, Hagler DJ, Reeder GS, Petty GW, et al. Patent Foramen Ovale in Cryptogenic Stroke: current understanding and management options. Arch Intern Med. 2004;164(9):950–956. PMID: 15136302 https://doi.org/10.1001/archinte.164.9.950; Yanagawa S, Ito N, Arima K, Ikeda S. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Neurology. 2002;58(5):817–820. PMID: 11889251 https://doi.org/10.1212/wnl.58.5.817; Chan MY, Andreotti F, Becker RC. Hypercoagulable states in cardiovascular disease. Circulation. 2008;118(22):2286–97. PMID: 19029477 https://doi.org/10.1161/CIRCULATIONAHA.108.778837; Schuchlenz HW, Weihs W, Horner S, Quehenberger F. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med. 2000;109(6):456–462. PMID: 11042234 https://doi.org/10.1016/s0002-9343(00)00530-1; Kimura K, Minematsu K, Wada K, Yasaka M, Tagaya M, Kuribayashi S, et al. Transcranial Doppler of a paradoxical brain embolism associated with a pulmonary arteriovenous fistula. AJNR Am J Neuroradiol. 1999;20(10):1881–1884. PMID: 10588113; Churton T. Multiple aneurysms of the pulmonary artery. Br Med J. (Clin Res Ed.). 1897; 1: 1223.; Westerman LP, Green D, Gilman-Sachs A, Beaman K, Freels S, Boggio L, et al. Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med. 1999;134(4):352–362. PMID: 10521081; McDermott S, Oliveira G, Ergül E, Brazeau N, Wicky S, Oklu R. MayThurner syndrome: can it be diagnosed by a single MR venography study. Diagn Interv Radiol. 2013;19(1):44–48. PMID: 22801870 https://doi.org/10.4261/1305-3825.DIR.5939-12.1; Crowther MA, Ginsberg JS, Julian J, Denburg J, Hirsh J, Douketis J, et al. A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome. N Engl J Med. 2003;349(12):1133–1138. PMID: 13679527 https://doi.org/10.1056/NEJMoa035241; Kiernan TJ, Yan BP, Cubeddu RJ, Rengifo-Moreno P, Gupta V, Inglessis I, et al. May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association. Stroke. 2009;40(4):1502–1504. PMID: 19182088 https://doi.org/10.1161/STROKEAHA.108.527366; Varona JF, Guerra JM, Bermejo F, Molina JA, Gomez de la Cámara A. Causes of ischemic stroke in young adults, and evolution of the etiological diagnosis over the long term. Eur Neurol. 2007;57(4):212– 218. PMID: 17268202 https://doi.org/10.1159/000099161; Nagel MA, Cohrs RJ, Mahalingam R, Wellish MC, Forghani B, Schiller A, et al. The Varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology. 2008;70(11):853–860. PMID: 18332343 https://doi.org/10.1212/01.wnl.0000304747.38502.e8; Caplan LR. Dissections of brain-supplying arteries. Nat Clin Pract Neurol. 2008;4(1):34–42. PMID: 18199995 https://doi.org/10.1038/ncpneuro0683; Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009;8(8):731–740. PMID: 19608099 https://doi.org/10.1016/S1474-4422(09)70134-6; Askalan R, Laughlin S, Mayank S, Chan A, MacGregor D, Andrew M, et al. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke. 2001;32(6):1257–1262. PMID: 11387484 https://doi.org/10.1161/01.str.32.6.1257; Kang JH, Ho JD, Chen YH, Lin HC. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke. 2009;40(11):3443–3448. PMID:19815828 https://doi.org/10.1161/STROKEAHA.109.562017; Nouh A, Hussain M, Mehta T, Yaghi S. Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice. Front Neurol. 2016;7:37. PMID: 27047443 https://doi.org/10.3389/fneur.2016.00037; Sajedi PI, Gonzalez JN, Cronin CA, Kouo T, Steven A, Zhuo J, et al. Carotid Bulb Webs as a Cause of “Cryptogenic” Ischemic Stroke. AJNR Am J Neuroradiology. 2017;38(7):1399–1404. PMID: 28495950 https://doi.org/10.3174/ajnr.A5208; Amarenco P, Davis S, Jones EF, Cohen AA, Heiss WD, Kaste M, et al. The Aortic Arch Related Cerebral Hazard Trial Investigators. Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques. Stroke. 2014;45(5):1248–1257. PMID:24699050 https://doi.org/10.1161/STROKEAHA.113.004251; Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288–294. PMID: 9414296; Koshy M, Thomas C, Goodwin J. Vascular lesions in the central nervous system in sickle cell disease (neuropathology). J Assoc Acad Minor Phys. 1990;1(3):71–78. PMID: 2136620; Razdan S, Strouse JJ, Naik R, Lanzkron S, Urrutia V, Resar JR, et al. Patent Foramen Ovale in Patients with Sickle Cell Disease and Stroke: Case Presentations and Review of the Literature. Case Rep Hematol. 2013;2013: 516705. PMID: 23956892 https://doi.org/10.1155/2013/516705; Bertina R.M., Koeleman B.P., Koster T., Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64–67. PMID: 8164741 https://doi.org/10.1038/369064a0; Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet. 2005; 365(9455): 224–232. PMID: 15652605 https://doi.org/10.1016/S0140-6736(05)17742-3; Morris JG, Singh S, Fisher M. Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good? Stroke. 2010;41(12):2985–2990. PMID: 20947844 https://doi.org/10.1161/STROKEAHA.110.595199; Aznar J, Mira Y, Vayб A, Corella D, Ferrando F, Villa P, et al. Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke. Thromb Haemost. 2004;91(5):1031–1034. PMID:15116266 https://doi.org/10.1160/TH03-11-0690; De Stefano V, Chiusolo P, Paciaroni K, Casorelli I, Rossi E, Molinari M, et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood. 1998; 91(10): 3562–3565. PMID: 9572989; Casas JP, Hingorani AD, Bautista LE, Sharma P. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol. 2004;61(11):1652–1661. PMID: 15534175 https://doi.org/10.1001/archneur.61.11.1652; Holmes MV, Newcombe P, Hubacek JA, Sofat R, Ricketts SL, Cooper J, et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet. 2011;378(9791):584–594. PMID: 21803414 https://doi.org/10.1016/S0140-6736(11)60872-6; Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveira S, Plomaritoglou A, et al. Homocysteine, MTHFR 677C→T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology. 2002;59(4):529–536. PMID: 12196644 https://doi.org/10.1212/wnl.59.4.529; Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J. 2003;146(6):948–957. PMID: 14660985 https://doi.org/10.1016/S0002-8703(03)00519-2; Pezzini A, Grassi M, Del Zotto E, Lodigiani C, Ferrazzi P, Spalloni A, et al. Common genetic markers and prediction of recurrent events after ischemic stroke in young adults. Neurology. 2009;73(9):717–723. PMID: 19720979 https://doi.org/10.1212/WNL.0b013e3181b59aaf; Patel ML, Sachan R, Seth G. Combined deficiency of proteins C and S: ischaemic stroke in young individuals. BMJ Case Reports. 2013;2013: pii: bcr2012008016. PMID: 24334463 https://doi.org/10.1136/bcr-2012008016; Brey RL, Stallworth CL, McGlasson DL, Wozniak MA, Wityk RJ, Stern BJ, et al. Antiphospholipid antibodies and stroke in young women. Stroke. 2002;33(10):2396–2400. PMID: 12364727 https://doi.org/10.1161/01.str.0000031927.25510.d1; Levine SR, Brey RL, Tilley BC, Thompson JL, Sacco RL, Sciacca RR, et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA. 2004;291(5):576–584. PMID: 14762036 https://doi.org/10.1001/jama.291.5.576; Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. The Antiphospholipid Antibodies in Stroke Study (APASS) Group. Neurology. 1993;43(10):2069–2073. PMID: 8413969; Tohgi H, Takahashi H, Kashiwaya M, Watanabe K, Hayama K. The anticardiolipin antibody in elderly stroke patients: its effects on stroke types, recurrence, and the coagulation-fibrinolysis system. Acta Neurol Scand. 1994;90(2):86–90. PMID: 7801744; Levine SR, Salowich-Palm L, Sawaya KL, Perry M, Spencer HJ, Winkler HJ, et al. IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death: a prospective cohort study. Stroke. 1997;28(9):1660–1665. PMID: 9303006 https://doi.org/10.1161/01.str.28.9.1660; Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke. 1992;23(2):189–193. PMID: 1561646 https://doi.org/10.1161/01.str.23.2.189; Karttunen V, Alfthan G, Hiltunen L, Rasi V, Kervinen K, Kesäniemi YA, et al. Risk factors for cryptogenic ischaemic stroke. Eur J Neurol. 2002;9(6):625–632 PMID: 12453078; Vayá A, Ejarque I, Tembl J, Corella D, Laiz B. Hyperhomocysteinemia, obesity and cryptogenic stroke. Clin Hemorheol Microcirc. 2011;47(1):53– 58. PMID: 21321408 https://doi.org/10.3233/CH-2010-1365; Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI. Association between high homocyst(e)ine and ischemic stroke due to largeand small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke. 2000;31(5):1069–1075. PMID: 10797167 https://doi.org/10.1161/01.str.31.5.1069; Klatsky AL, Armstrong MA, Friedman GD, Sidney S. Alcohol drinking and risk of hemorrhagic stroke. Neuroepidemiology. 2002;21(3):115– 122. PMID: 12006774 https://doi.org/10.1159/000054808; Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270(22):2693–2698. PMID: 8133587 https://doi.org/10.1001/jama.1993.03510220049033; Weintraub G, Sprecace G. Paroxysmal atrial fibrillation and cerebral embolism with apparently normal heart. N Engl J Med. 1958;259(18):875– 876. PMID: 13590468 https://doi.org/10.1056/NEJM195810302591807; Hassan A, Sham PC, Markus HS. Planning genetic studies in human stroke Sample size estimates based on family history data. Neurology. 2002;58(10):1483–1488. PMID: 12034783 https://doi.org/10.1212/wnl.58.10.1483; Chabriat H, Levy C, Taillia H, Iba-Zizen MT, Vahedi K, Joutel A, et al. Patterns of MRI lesions in CADASIL. Neurology. 1998;51(2):452–457. PMID: 9710018 https://doi.org/10.1212/wnl.51.2.452; O’Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001;56(5):628–634. PMID: 11245715 https://doi.org/10.1212/wnl.56.5.628; Fukutake T. Young-adult-onset hereditary subcortical vascular dementia: cerebral autosomal recessive arteriosclerosis with subcortical infarcts and leukoencephalopathy (CARASIL). Rinsho Shinkeigaku. 1999; 39(1): 50–52. PMID: 10377800; Star M, Gill R, Bruzzone M, De Alba F, Schneck MJ, Biller J. Do not forget Susac syndrome in patients with unexplained acute confusion. J Stroke Cerebrovasc Dis. 2015;24(4):e93–95. PMID: 25680663 https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.11.028; Jen J, Cohen AH, Yue Q, Stout JT, Vinters HV, Nelson S, et al. Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology. 1997;49(5):1322–1330. PMID: 9371916 https://doi.org/10.1212/wnl.49.5.1322; Olin JW, Kaufman JA, Bluemke DA, Bonow RO, Gerhard MD, Jaff MR, et al. Atherosclerotic Vascular Disease Conference: writing Group IV: imaging. Circulation. 2004;109(21):2626-2633. PMID:15173045 https://doi.org/10.1161/01.CIR.0000128521.02390.72; Desnick RJ, Ioannou YA, Eng CM. Galactosidase a deficiency: fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D. (eds.) The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw Hill; 2001. p.3733–3774.; Moore DF, Kaneski CR, Askari H, Schiffmann R. The cerebral vasculopathy of Fabry disease. J Neurol Sci. 2007;257(1–2):258–263. PMID: 17362993 https://doi.org/10.1016/j.jns.2007.01.053; Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003;138(4):338–346. PMID: 1258533 https://doi.org/10.7326/0003-4819-138-4-200302180-00014; Manara R, Carlier RY, Righetto S, Citton V, Locatelli G, Colas F, et al. Basilar Artery Changes in Fabry Disease. AJNR Am J Neuroradiol. 2017;38(3):531–536. PMID: 28126747 https://doi.org/10.3174/ajnr.A5069.; Moore DF, Ye F, Schiffmann R, Butman JA. Increased signal intensity in the pulvinar on T1weighted images: a pathognomonic MR imaging sign of Fabry disease. AJNR Am J Neuroradiol. 2003;24(6):1096–1101. PMID: 12812932; Rolfs A, Böttcher T, Zschiesche M, Morris P, Winchester B, Bauer P, et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet. 2005;366(9499):1794–1796. PMID: 16298216 https://doi.org/10.1016/S0140-6736(05)67635-0; Sims K, Politei J, Banikazemi M, Lee P. Stroke in Fabry Disease Frequently Occurs Before Diagnosis and in the Absence of Other Clinical Events Natural History Data From the Fabry Registry. Stroke. 2009;40(3):788– 794. PMID: 19150871 https://doi.org/10.1161/STROKEAHA.108.526293; Grisold W, Oberndorfer S, Struhal W. Stroke and cancer: a review. Acta Neurol Scand. 2009;119(1):1–16. PMID: 18616624 https://doi.org/10.1111/j.1600-0404.2008.01059.x; Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine (Baltimore). 1985;64(1):16–35. PMID: 3965856; Kim SJ, Park JH, Lee MJ, Park YG, Ahn MJ, Bang OY. Clues to occult cancer in patients with ischemic stroke. PLoS One. 2012;7(9):e44959. PMID: 22984594 https://doi.org/10.1371/journal.pone.0044959; Schwarzbach CJ, Schaefer A, Ebert A, Held V, Bolognese M, Kablau M, et al. Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology. Stroke. 2012;43(11):3029–3034. PMID: 22996958 https://doi.org/10.1161/STROKEAHA.112.658625; Kim SG, Hong JM, Kim HY, Held V, Bolognese M, Kablau M, et al. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke. 2010;41(4):798–801. PMID: 20150545 https://doi.org/10.1161/STROKEAHA.109.571356; Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin. 2003;21(1):167–192. PMID: 12690649; Steiner I. Nonbacterial thrombotic endocarditis – a study of 171 case reports. Cesk Patol. 1993;29(2):58–60. PMID: 8339326; Ojeda VJ, Frost F, Mastaglia FL. Non-bacterial thrombotic endocarditis associated with malignant disease: a clinicopathological study of 16 cases. Med J Aust. 1985;142(12):629–631. PMID: 4000038; https://www.jnmp.ru/jour/article/view/691

Διαθεσιμότητα: https://www.jnmp.ru/jour/article/view/691
https://doi.org/10.23934/2223-9022-2019-8-3-302-314

Patent foramen ovale and embolic cryptogenic stroke ; Открытое овальное окно и эмболический криптогенный инсульт

Συγγραφείς: A. A. Kulesh, V. V. Shestakov, А. А. Кулеш, В. В. Шестаков

Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 11, No 2 (2019); 4-11 ; Неврология, нейропсихиатрия, психосоматика; Vol 11, No 2 (2019); 4-11 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2019-2

Θεματικοί όροι: окклюзия, paradoxical embolism, cryptogenic stroke, occlusion, парадоксальная эмболия, криптогенный инсульт

Περιγραφή αρχείου: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/1093/871; Nouh A, Hussain M, Mehta T, Yaghi S. Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice. Front Neurol. Front Neurol. 2016 Mar 21;7:37. doi:10.3389/fneur.2016.00037. eCollection 2016.; Hart RG, Diener HC, Coutts SB, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014 Apr;13(4):429-38. doi:10.1016/S14744422(13)70310-7.; Perera KS, Swaminathan B, Veltkamp R, et al. Frequency and features of embolic stroke of undetermined source in young adults. European Stroke Journal. 2018;3(2):110-6.; Шамалов НА, Кустова МА. Криптогенный инсульт. Неврология, нейропсихиатрия, психосоматика. 2014;6(2S):42-9. Doi:10.14412/2074-2711-2014-2S-42-49; Saver JL, Mattle HP, Thaler D. Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review. Stroke. 2018 Jun;49(6):1541-1548. doi:10.1161/STROKEAHA.117.018153. Epub 2018 May 14.; Sun YP, Homma S. Patent Foramen Ovale and Stroke. Circ J. 2016 Jul 25;80(8):1665-73. doi:10.1253/circj.CJ-16-0534. Epub 2016 Jun 22.; Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009 Jul;40(7):2349-55. doi:10.1161/STROKEAHA.109.547828. Epub 2009 May 14.; Ryoo S, Chung JW, Lee MJ, et al. An Approach to Working Up Cases of Embolic Stroke of Undetermined Source. J Am Heart Assoc. 2016 Mar 22;5(3):e002975. doi:10.1161/JAHA.115.002975.; Lee PH, Song JK, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale: the defense-pfo trial. J Am Coll Cardiol. 2018 May 22;71(20):2335-2342. doi:10.1016/j.jacc.2018.02.046. Epub 2018 Mar 12.; Mazzucco S, Li L, Binney L, Rothwell PM; Oxford Vascular Study Phenotyped Cohort. Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and nondisabling stroke at older ages: a populationbased study, systematic review, and meta-analysis. Lancet Neurol. 2018 Jul;17(7):609-617. doi:10.1016/S1474-4422(18)30167-4. Epub 2018 Jun 7.; Mojadidi MK, Zaman MO, Elgendy IY, et al. Cryptogenic Stroke and Patent Foramen Ovale. J Am Coll Cardiol. 2018 Mar 6;71(9): 1035-1043. doi:10.1016/j.jacc.2017.12.059.; Wessler BS, Thaler DE, Ruthazer R, et al. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging. 2014 Jan;7(1):125-31. doi:10.1161/CIRCIMAGING.113.000807. Epub 2013 Nov 8.; Пизова НВ. Заболевания сердца и инсульты у лиц молодого возраста. Неврология, нейропсихиатрия, психосоматика. 2014;6(2):62-9. doi:10.14412/2074-27112014-2-62-69; Bayar N, Arslan S, Cagirci G, et al. Assessment of morphology of patent foramen ovale with transesophageal echocardiography in symptomatic and asymptomatic patients. J Stroke Cerebrovasc Dis. 2015 Jun;24(6):1282-6. doi:10.1016/j.jstrokecerebrovasdis.2015.01.036. Epub 2015 Apr 20.; Ozdemir AO, Tamayo A, Munoz C, et al. Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism. J Neurol Sci. 2008 Dec 15;275(1-2):121-7. doi:10.1016/j.jns.2008.08.018. Epub 2008 Sep 26.; Cramer SC, Rordorf G, Maki JH, et al. Increased pelvic vein thrombi in cryptogenic stroke: Results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke. 2004 Jan;35(1):46-50. Epub 2003 Dec 4.; Liberman AL, Daruwalla VJ, Collins JD, et al. Diagnostic yield of pelvic magnetic resonance venography in patients with cryptogenic stroke and patent foramen ovale. Stroke. 2014 Aug; 45(8):2324-9. doi:10.1161/STROKEAHA.114.005539. Epub 2014 Jun 17.; Osgood M, Budman E, Carandang R, et al. Prevalence of pelvic vein pathology in patients with cryptogenic stroke and patent foramen ovale undergoing MRV pelvis. Cerebrovasc Dis. 2015;39(3-4):216-23. doi:10.1159/000376613. Epub 2015 Mar 14.; Kiernan TJ, Yan BP, Cubeddu RJ, et al. May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association. Stroke. 2009 Apr; 40(4):1502-4. doi:10.1161/STROKEAHA.108.527366. Epub 2009 Jan 29.; West BH, Noureddin N, Mamzhi Y, et al. Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke. Stroke. 2018 May;49(5):1123-1128. doi:10.1161/STROKEAHA.117.020160. Epub 2018 Apr 10.; Snijder RJ, Luermans JG, de Heij AH, et al. Patent Foramen Ovale With Atrial Septal Aneurysm Is Strongly Associated With Migraine With Aura: A Large Observational Study. J Am Heart Assoc. 2016 Dec 1;5(12). pii: e003771.; Mojadidi MK, Bokhoor PI, Gevorgyan R, et al. Sleep apnea in patients with and without a right-to-left shunt. J Clin Sleep Med. 2015 Nov 15;11(11):1299-304. doi:10.5664/jcsm.5190.; Thaler DE, Ruthazer R, Di Angelantonio E, et al. Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovale. Stroke. 2013 Mar;44(3):675-80. doi:10.1161/STROKEAHA.112.677039. Epub 2013 Jan 22.; Hayashida K, Fukuchi K, Inubushi M, et al. Embolic distribution through patent foramen ovale demonstrated by (99m) Tc-MAA brain SPECT after Valsalva radionuclide venography. J Nucl Med. 2001 Jun;42(6):859-63.; Kim BJ, Sohn H, Sun BJ, et al. Imaging characteristics of ischemic strokes related to patent foramen ovale. Stroke. 2013 Dec;44(12): 3350-6. doi:10.1161/STROKEAHA.113.002459. Epub 2013 Sep 26.; Bang OY, Lee MJ, Ryoo S, et al. Patent Foramen Ovale and Stroke-Current Status. J Stroke. 2015 Sep;17(3):229-37. doi:10.5853/jos.2015.17.3.229. Epub 2015 Sep 30.; Akhondi A, Gevorgyan R, Tseng CH, et al. The association of patent foramen ovale morphology and stroke size in patients with paradoxical embolism. Circ Cardiovasc Interv. 2010 Oct;3(5):506-10. doi:10.1161/CIRCINTERVENTIONS.109.908533. Epub 2010 Sep 21.; Kim JW, Kim SJ, Yoon CW, et al. Association between the amount of right-to-left shunt and infarct patterns in patients with cryptogenic embolic stroke: a transcranial Doppler study. Int J Stroke. 2013 Dec;8(8):657-62. doi:10.1111/j.1747-4949.2012.00846.x. Epub 2012 Jul 19.; Liu JR, Plц tz BM, Rohr A, et al. Association of right to-left shunt with frontal white matter lesions in T2-weighted MR imaging of stroke patients. Neuroradiology. 2009 May;51(5):299-304. doi:10.1007/s00234-0090496-9. Epub 2009 Jan 23.; Di Tullio MR, Jin Z, Russo C, et al. Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. J Am Coll Cardiol. 2013 Jul 2;62(1): 35-41. doi:10.1016/j.jacc.2013.03.064. Epub 2013 May 1.; Kim SJ, Shin HY, Ha YS, et al. Paradoxical embolism as a cause of silent brain infarctions in healthy subjects: the ICONS study (Identification of the Cause of Silent Cerebral Infarction in Healthy Subjects). Eur J Neurol. 2013 Feb;20(2):353-60. doi:10.1111/j.14681331.2012.03864.x. Epub 2012 Sep 9.; Silvestry FE, Cohen MS, Armsby LB, et al. American Society of Echocardiography; Society for Cardiac Angiography and Interventions. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr. 2015 Aug;28(8):910-58. doi:10.1016/j.echo.2015.05.015.; Mahmoud AN, Elgendy IY, Agarwal N, et al. Identification and quantification of patent foramen ovale mediated shunts: echocardiography and transcranial Doppler. Interv Cardiol Clin. 2017 Oct;6(4):495-504. doi:10.1016/j.iccl.2017.05.002. Epub 2017 Jun 27.; Johansson MC, Helgason H, Dellborg M, Eriksson P. Sensitivity for detection of patent foramen ovale increased with increasing number of contrast injections: A descriptive study with contrast transesophageal echocardiography. J Am Soc Echocardiogr. 2008 May;21(5):419-24. Epub 2007 Oct 10.; Schneider B, Zienkiewicz T, Jansen V, et al. Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol. 1996 Jun 1;77(14):1202-9.; Katsanos AH, Psaltopoulou T, Sergentanis TN, et al. Transcranial Doppler versus transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: A systematic review and diagnostic test accuracy meta-analysis. Ann Neurol. 2016 Apr;79(4):625-35. doi:10.1002/ana.24609. Epub 2016 Mar 11.; Droste DW, Lakemeier S, Wichter T, et al. Optimizing the technique of contrast transcranial Doppler ultrasound in the detection of right-to-left shunts. Stroke. 2002 Sep;33(9): 2211-6.; Mojadidi MK, Roberts SC, Winoker JS, et al. Accuracy of transcranial Doppler for the diagnosis of intracardiac right-to left shunt: a bivariate meta-analysis of prospective studies. Review. JACC Cardiovasc Imaging. 2014 Mar;7(3): 236-50. doi:10.1016/j.jcmg.2013.12.011. Epub 2014 Feb 19.; Serena J, Segura T, Perez-Ayuso MJ, et al. The need to quantify right-to-left shunt in acute ischemic stroke: A case-control study. Stroke. 1998 Jul;29(7):1322-8.; Mojadidi MK, Gevorgyan R, Tobis JM. A comparison of methods to detect and quantitate PFO: TCD, TTE, ICE and TEE. In: Amin Z, Tobis J, Sievert H, Carroll J, editors. Patent Foramen Ovale. London: Springer; 2015. P. 55-65.; Meissner I, Khandheria BK, Heit JA, et al. Patent foramen ovale: Innocent or guilty?: Evidence from a prospective population-based study. J Am Coll Cardiol. 2006 Jan 17;47(2): 440-5. Epub 2005 Dec 6.; Lopez MF, Krastins B, Sarracino DA, et al. Proteomic signatures of serum albumin-bound proteins from stroke patients with and without endovascular closure of PFO are significantly different and suggest a novel mechanism for cholesterol efflux. Clin Proteomics. 2015 Jan 13; 12(1):2. doi:10.1186/1559-0275-12-2. eCollection 2015.; Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013 Aug 13;81(7):619-25. doi:10.1212/WNL.0b013e3182a08d59. Epub 2013 Jul 17.; Thijs VN, Brachmann J, Morillo CA, et al. Predictors for atrial fibrillation detection after cryptogenic stroke: results from CRYSTAL AF. Neurology. 2016 Jan 19;86(3):261-9. doi:10.1212/WNL.0000000000002282. Epub 2015 Dec 18.; Saver JL. Cryptogenic stroke. N Engl J Med. 2016 May 26;374(21):2065-74. doi:10.1056/NEJMcp1503946.; Lapergue B, Decroix JP, Evrard S, et al. Diagnostic yield of venous thrombosis and pulmonary embolism by combined CT venography and pulmonary angiography in patients with cryptogenic stroke and patent foramen ovale. Eur Neurol. 2015;74(1-2):69-72. doi:10.1159/000437261. Epub 2015 Jul 25.; Kobayashi N, Karino T. Flow behavior and distribution of embolus-model particles at the terminal bifurcation of the human internal carotid artery. World Neurosurg. 2016 Jun;90: 469-477. doi:10.1016/j.wneu.2016.03.012. Epub 2016 Mar 14.; Кулеш АА, Голосова ЮА, Сыромятникова ЛИ, Шестаков ВВ. Дополнительные клинические и инструментально-лабораторные маркёры основных патогенетических вариантов ишемического инсульта. Клиническая медицина. 2018;96(3):240-7.; Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Jul;45(7): 2160-236. doi:10.1161/STR.0000000000000024. Epub 2014 May 1.; Парфенов ВА, Вербицкая СВ. Вторичная профилактика ишемического инсульта: международные рекомендации и клиническая практика. Неврологический журнал. 2014;19(2):4-10.; Парфенов ВА, Вербицкая СВ. Вторичная профилактика инсульта при фибрилляции предсердий, применение апиксабана (исследования aristotle, averroes). Неврология, нейропсихиатрия, психосоматика. 2014; 6(2S):7-14. doi:10.14412/2074-2711-2014-2S-7-14; Парфенов ВА, Вербицкая СВ. Факторы риска и профилактика инсульта при фибрилляции предсердий. Неврология, нейропсихиатрия, психосоматика. 2014;6(3):55-60. doi:10.14412/2074-2711-2014-3-55-60; Mas JL, Derumeaux G, Guillon B, et al; CLOSE Investigators. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017 Sep 14;377(11): 1011-1021. doi:10.1056/NEJMoa1705915.; Homma S, Sacco RL, Di Tullio MR, et al. PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002 Jun 4;105(22):2625-31.; Kent DM, Dahabreh IJ, Ruthazer R, et al. Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta analysis. Eur Heart J. 2015 Sep 14;36(35): 2381-9. doi:10.1093/eurheartj/ehv252. Epub 2015 Jul 3.; Парфенов ВА. Профилактика венозных тромбоэмболических осложнений при ишемическом инсульте. Неврология, нейропсихиатрия, психосоматика. 2013;5(3):49-54. doi:10.14412/2074-2711-2013-2341; Hornung M, Bertog SC, Franke J, et al. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale. Eur Heart J. 2013 Nov;34(43):3362-9. doi:10.1093/eurheartj/eht283. Epub 2013 Jul 9.; S∅ndergaard L, Kasner SE, Rhodes JF, et al; Gore REDUCE Clinical Study Investigators. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017 Sep 14;377(11):1033-1042. doi:10.1056/NEJMoa1707404.; Carroll JD, Saver JL, Thaler DE, et al; RESPECT Investigators. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. RESPECT Investigators. N Engl J Med. 2013 Mar 21;368(12):1092-100. doi:10.1056/NEJMoa1301440.; Sitwala P, Khalid MF, Khattak F, et al. Percutaneous closure of patent foramen ovale in patients with cryptogenic stroke – An updated comprehensive meta-analysis. Cardiovasc Revasc Med. 2018 Sep 19. pii: S1553-8389(18)30412-3. doi:10.1016/j.carrev.2018.09.010. [Epub ahead of print]

Διαθεσιμότητα: https://nnp.ima-press.net/nnp/article/view/1093
https://doi.org/10.14412/2074-2711-2019-2-4-11

ИШЕМИЧЕСКИЙ ИНСУЛЬТ У МОЛОДОЙ ЖЕНЩИНЫ ВСЛЕДСТВИЕ ПАРАДОКСАЛЬНОЙ ЭМБОЛИИ, АССОЦИИРОВАННОЙ С ОТКРЫТЫМ ОВАЛЬНЫМ ОКНОМ И ПРИЕМОМ ГОРМОНАЛЬНЫХ КОНТРАЦЕПТИВОВ

Συγγραφείς: ЕВТУШЕНКО И.С., СИМАНОВ Р.В., ЕВТУШЕНКО С.К., СИМОНЯН В.А.

Θεματικοί όροι: ИШЕМИЧЕСКИЙ ИНСУЛЬТ,ISCHEMIC STROKE,ОТКРЫТОЕ ОВАЛЬНОЕ ОКНО,ПАРАДОКСАЛЬНАЯ ЭМБОЛИЯ,PARADOXICAL EMBOLISM,КОНТРАЦЕПТИВЫ,CONTRACEPTIVES,іШЕМіЧНИЙ іНСУЛЬТ,ВіДКРИТЕ ОВАЛЬНЕ ВіКНО,ПАРАДОКСАЛЬНА ЕМБОЛіЯ,КОНТРАЦЕПТИВИ,PATENT FORAMEN OVALE

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/ishemicheskiy-insult-u-molodoy-zhenschiny-vsledstvie-paradoksalnoy-embolii-assotsiirovannoy-s-otkrytym-ovalnym-oknom-i-priemom
http://cyberleninka.ru/article_covers/16491629.png

ОТКРЫТОЕ ОВАЛЬНОЕ ОКНО И КРИПТОГЕННЫЙ ИНСУЛЬТ

Συγγραφείς: Фазлиахметова, А., Мамедов, Х.

Θεματικοί όροι: ОТКРЫТОЕ ОВАЛЬНОЕ ОКНО, ПАРАДОКСАЛЬНАЯ ЭМБОЛИЯ, ИШЕМИЧЕСКИЙ ИНСУЛЬТ

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/otkrytoe-ovalnoe-okno-i-kriptogennyy-insult
http://cyberleninka.ru/article_covers/15425682.png

Патогенетическая гетерогенность ишемического инсульта и открытое овальное отверстие

Συγγραφείς: Суслина, З., Фонякин, А., Чечеткин, А., Глебов, М., Гераскина, Л., Никитин, Ю., Кравченко, М.

Θεματικοί όροι: ОТКРЫТОЕ ОВАЛЬНОЕ ОТВЕРСТИЕ,ПАРАДОКСАЛЬНАЯ ЭМБОЛИЯ,ИШЕМИЧЕСКИЙ ИНСУЛЬТ

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/patogeneticheskaya-geterogennost-ishemicheskogo-insulta-i-otkrytoe-ovalnoe-otverstie
http://cyberleninka.ru/article_covers/14622464.png

ИШЕМИЧЕСКИЙ ИНСУЛЬТ У МОЛОДОЙ ЖЕНЩИНЫ ВСЛЕДСТВИЕ ПАРАДОКСАЛЬНОЙ ЭМБОЛИИ, АССОЦИИРОВАННОЙ С ОТКРЫТЫМ ОВАЛЬНЫМ ОКНОМ И ПРИЕМОМ ГОРМОНАЛЬНЫХ КОНТРАЦЕПТИВОВ

Πηγή: Международный неврологический журнал.

Θεματικοί όροι: ИШЕМИЧЕСКИЙ ИНСУЛЬТ,ISCHEMIC STROKE,ОТКРЫТОЕ ОВАЛЬНОЕ ОКНО,ПАРАДОКСАЛЬНАЯ ЭМБОЛИЯ,PARADOXICAL EMBOLISM,КОНТРАЦЕПТИВЫ,CONTRACEPTIVES,іШЕМіЧНИЙ іНСУЛЬТ,ВіДКРИТЕ ОВАЛЬНЕ ВіКНО,ПАРАДОКСАЛЬНА ЕМБОЛіЯ,КОНТРАЦЕПТИВИ,PATENT FORAMEN OVALE, 3. Good health

Περιγραφή αρχείου: text/html

Σύνδεσμος πρόσβασης: http://cyberleninka.ru/article_covers/16491629.png
http://cyberleninka.ru/article/n/ishemicheskiy-insult-u-molodoy-zhenschiny-vsledstvie-paradoksalnoy-embolii-assotsiirovannoy-s-otkrytym-ovalnym-oknom-i-priemom

Открытое овальное окно и криптогенный инсульт

Πηγή: Практическая медицина.

Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, ОТКРЫТОЕ ОВАЛЬНОЕ ОКНО, ПАРАДОКСАЛЬНАЯ ЭМБОЛИЯ, ИШЕМИЧЕСКИЙ ИНСУЛЬТ, 3. Good health

Περιγραφή αρχείου: text/html

Σύνδεσμος πρόσβασης: http://cyberleninka.ru/article_covers/15425682.png
http://cyberleninka.ru/article/n/otkrytoe-ovalnoe-okno-i-kriptogennyy-insult

Патогенетическая гетерогенность ишемического инсульта и открытое овальное отверстие

Πηγή: Анналы клинической и экспериментальной неврологии.

Θεματικοί όροι: ОТКРЫТОЕ ОВАЛЬНОЕ ОТВЕРСТИЕ,ПАРАДОКСАЛЬНАЯ ЭМБОЛИЯ,ИШЕМИЧЕСКИЙ ИНСУЛЬТ

Περιγραφή αρχείου: text/html

Σύνδεσμος πρόσβασης: http://cyberleninka.ru/article/n/patogeneticheskaya-geterogennost-ishemicheskogo-insulta-i-otkrytoe-ovalnoe-otverstie
http://cyberleninka.ru/article_covers/14622464.png

Общее ученiе объ опухоляхъ

Συγγραφείς: Петровъ, Н. Н.

Θεματικοί όροι: опухоль, размножение клеток, фагоцитоз, парадоксальная эмболия

Περιγραφή αρχείου: application/pdf

Relation: Петровъ Н. Н. Общее ученiе объ опухоляхъ / Н. Н. Петровъ. – СПб, 1910. – 380 с.; https://repo.odmu.edu.ua:443/xmlui/handle/123456789/9634

Διαθεσιμότητα: https://repo.odmu.edu.ua:443/xmlui/handle/123456789/9634

Легочный артериовенозный шунт - редкая причина рецидивирующих нарушений мозгового кровообращения по механизму парадоксальной эмболии

Συγγραφείς: Белопасова А.В., Добрынина Л.А., Калашникова Л.А., Чечеткин А.О., Каршиева А.Р., Абугов С.А., Марданян Г.В., Пурецкий М.В., Штеклейн А.В.

Πηγή: Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Θεματικοί όροι: young stroke, pulmonary arteriovenous malformations, pulmonary shunt, pulmonary fistula, paradoxical embolism, Hereditary hemorrhagic telangiectasia, Rendu-Osler-Weber disease, инсульт в молодом возрасте, Легочные артериовенозные мальформации, легочный шунт, легочная фистула, парадоксальная эмболия, наследственная геморрагическая телеангиэктазия, болезнь Рандю-Ослера-Вебера

Relation: https://repository.rudn.ru/records/article/record/67529/

Διαθεσιμότητα: https://repository.rudn.ru/records/article/record/67529/